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ABSTRACT 
The production of reactive oxygen species (ROS) was long thought to be a necessary 
consequence of aerobic metabolism causing non-specific damage to proteins, lipids and DNA. 
In the last years, however, several studies showed that at low levels ROS can act as cellular 
signaling molecules. In particular, hydrogen peroxide (H2O2) gained interest as second 
messenger due to its long half-life, its compartmentalized production and its ability to 
reversibly oxidize specific thiol groups of proteins. Reversible oxidation leads to the formation 
of sulfenic acid (-SOH), altering protein structure and thereby protein function. One of the 
most established targets of H2O2-mediated oxidation are protein tyrosine phosphatases 
(PTPs). Their active site is characterized by the same signature motif including one cysteine 
with a low pKa, which is essential for catalyzing the dephosphorylation of tyrosines but also 
renders PTPs highly susceptible for oxidation resulting in their inactivation. Interestingly, it 
was shown that receptor tyrosine kinase (RTK) activation initiates the production of H2O2 by 
activating NAPDH oxidases (NOXs). This local burst of H2O2 leads to the coupling of RTK 
activation with PTP inhibition. 
So far, it was difficult to detect the spatial-temporal dynamics of H2O2 production and 
the resulting oxidation of proteins, remaining the precise role of PTP oxidation in RTK signal 
propagation unspecified. Here, we investigated the causal connectivity between PTP 
inhibition and activation of the epidermal growth factor receptor (EGFR) and how this 
network might be affected by oncogene-induced H2O2 production. We could show that 
ligand-dependent and -independent EGFR activation result in the production of H2O2. 
Cellular transformation through the constitutively active form of HRas (G12V mutant) even 
increases H2O2 levels in unstimulated cells and upon EGF stimulation. As a consequence, 
HRas G12V transformed cells are more susceptible for autonomous EGFR activation. In 
addition, we could show that proliferation and survival of oncogenic cells are dependent on 
elevated H2O2 levels. For a better understanding of the link between RTK activation and PTP 
inactivation, we developed a FRET-FLIM approach to monitor the spatial-temporal oxidation 
of proteins, tested here with the Src-homology protein tyrosine phosphatase 2 (SHP2). By 
using this method, we could show that SHP2 is more oxidized in HRas G12V transformed 
cells, most likely involved in the higher autonomous EGFR activation. A further investigation 
of how H2O2-mediated oxidation of other PTPs is affecting the RTK-PTP reaction network 
could give new insights into how the final RTK response is shaped under physiological and 
pathophysiological conditions. 
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ZUSAMMENFASSUNG 
Lange Zeit wurde die Bildung von reaktiven Sauerstoffspezies (Reactive oxygen species, 
ROS) als notwendiges Übel eines aeroben Stoffwechsels angesehen, das zur Schädigung von 
Proteinen, Lipiden und DNA führt. Allerdings zeigten mehrere Studien, dass bei niedrigen 
Konzentrationen ROS als zelluläre Signalmoleküle fungieren können. Vor allem 
Wasserstoffperoxid (H2O2) rückte in den Fokus als sekundärer Botenstoff, charakterisiert 
durch seine lange Halbwertszeit, die kompartimentalisierte Bildung und die Eigenschaft 
spezifische Thiolgruppen von Proteinen reversibel zu oxidieren. Die reversible Oxidierung 
führt zur Bildung von Sulfensäure (-SOH) und einer daraus resultierenden Modifikation der 
Proteinstruktur, was zu einer Änderung der Proteinfunktion führt. Zu der bekanntesten 
Zielgruppe von H2O2 vermittelter Oxidierung gehören Protein-Tyrosin-Phosphatasen (PTPs). 
Das aktive Zentrum von PTPs ist durch das gleiche Motiv gekennzeichnet, was ein Cystein 
mit niedrigem pKa beinhaltet. Dieser Cystein-Rest ist wichtig für die Phosphotyrosin-
Hydrolyse, macht PTPs aber gleichzeitig anfällig für eine oxidative Modifikation und einer 
damit verbundenen Inaktivierung. Interessanterweise konnte auch gezeigt werden, dass die 
Aktivierung von Rezeptortyrosin-Kinasen (RTKs) die Bildung von H2O2 verursacht. Der 
lokale Anstieg von H2O2 führt somit zur einer Kopplung zwischen der Aktivierung von RTKs 
und der Inhibierung von PTPs.  
Bis jetzt war es schwierig, die räumlichen und zeitlichen Dynamiken der H2O2 Bildung 
und der daraus resultierenden Proteinoxidierung zu detektieren, weswegen der Einfluss der 
PTP Oxidierung auf die RTK Signalweiterleitung weitestgehend ungeklärt ist. Der Fokus 
dieser Arbeit liegt auf der Untersuchung des kausalen Zusammenhangs zwischen PTP 
Inhibierung und der Aktivierung des epidermalen Wachstumsfaktor Rezeptors (epidermal 
growth factor receptor, EGFR) und ob dieses Netzwerk durch Onkogen-induzierte H2O2 
Produktion beeinflusst wird. Wir konnten zeigen, dass die Liganden-abhängige 
und -unabhängige Aktivierung von EGFR zu der Produktion von H2O2 führt. Maligne 
Zelltransformation durch die konstitutiv-aktive Form von HRas (G12V Mutante) erhöht die 
intrazellulären H2O2 Level zusätzlich, sowohl in unstimulierten als auch in EGF-stimulierten 
Zellen. Daraus resultiert, dass HRas G12V transformierte Zellen eine besonders hohe 
Anfälligkeit für eine autonome EGFR Aktivierung aufweisen. Zusätzlich konnte gezeigt 
werden, dass die Zellproliferation und das Überleben transformierter Zellen von der erhöhten 
H2O2 Produktion abhängig ist. Für einen tiefer Einblick in die Kopplung zwischen RTK 
Aktivierung und PTP Inhibierung wurde ein FRET-FLIM Ansatz entwickelt, um die 
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räumliche und zeitliche Oxidierung von Proteinen aufzulösen. Getestet wurde diese Methode 
an Hand der Oxidierung von der Src-homology Proteintyrosin Phosphatase 2 (SHP2). Es 
konnte gezeigt werden, dass HRas G12V transformierte Zellen eine erhöhte SHP2 Oxidierung 
aufweisen, was sehr wahrscheinlich zu der verstärkten autonomen EGFR Aktivierung beiträgt. 
Weiterführende Untersuchungen könnten Aufschluss darüber geben, inwieweit die 
Oxidierung von weiteren PTPs das RTK-PTP Reaktionsnetzwerk beeinflusst und wie dadurch 
die finale RTK Reaktion unter physiologischen und pathophysiologischen Bedingungen 
bestimmt wird.  
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1 INTRODUCTION 
1.1 ROS signaling 
Reactive oxygen species (ROS) is a collective term that describes O2-derived species 
including superoxide anion (O2-), hydrogen peroxide (H2O2) and hydroxyl radical (HO)1. 
The intracellular production of ROS was long believed to be a necessary evil of aerobic life 
that cannot be avoided2. Nearly every metabolic process is coupled to the generation of small 
amounts of ROS due to incomplete reduction of oxygen, with the mitochondrion as one of the 
major intracellular sources3. High concentrations, referred to as oxidative stress, are 
implicated in various disease states such as atherosclerosis, diabetes, cancer, 
neurodegeneration and aging4. However, ROS involvement in the pathogenesis of diseases is 
not confined to macromolecular damage but rather their specific role in affecting cellular 
signaling. Furthermore, many studies now provided evidence for the role of ROS not only in 
pathologies but also in physiological signaling processes. 
The implication of ROS as possible second messenger is still controversial but raising 
more and more interest in the scientific community. The paradox that a rather toxic 
byproduct should mediate important signaling processes and regulate cellular functions such 
as survival and proliferation is still not fully explained yet. How can a molecule, which 
recognition occurs at the atomic and not the macromolecular level, that has short half-lives 
and targets ranging from proteins to lipids to DNA and RNA, guarantee specificity in cellular 
signaling cascades? With this work we want to render the understanding of ROS signaling 
activities more precisely with the focus on hydrogen peroxide (H2O2).  
Going back in the history of ROS biology, the first proteins found important for redox 
(reduction/oxidation) signaling were ROS scavengers such as catalase, peroxiredoxins (PRXs) 
and superoxide dismutases (SODs). They are part of the antioxidant machinery of cells 
removing excess radicals. Their discovery supported the view of ROS as an unavoidable 
component of aerobic metabolism that need to be reduced quickly upon formation. On the 
other hand, high H2O2 levels near the endoplasmic reticulum, necessary for proper protein 
folding, was an accepted exception for biological relevant ROS production. It was shown that 
the protein ER oxidoreductin 1 (Ero1) initiates the formation of disulphide bonds by 
triggering a two-electron oxidation of the thioredoxin protein disulfide isomerase (PDI) 
leading to the production of H2O25. Another biological function of controlled ROS production 
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is long known for leucocytes, cells of the innate immune response. During phagocytosis ROS 
gets produced in high levels to kill harmful microbial intruders resulting in the so called 
‘respiratory burst’6. Otherwise, elevated ROS levels were only associated with cellular damage 
and genomic instability prompting cell death, aging and carcinogenesis7.  
Rethinking started with a few reports in the 1980s showing that low concentrations of 
exogenous H2O2 could stimulate cell proliferation8. Further investigations focused on the 
phagocytic enzyme gp91phox (now known as NOX2) responsible for the respiratory burst in 
leucocytes. Through gene profiling, seven isoforms (NOX1-5 and DUOX 1 and 2) of NOX2 
were found with a ubiquitous expression also in non-phagocytic cells3,9. It became apparent 
that production of ROS has a more global role than just for microbe killing. In particular O2- 
and H2O2, the main products of NOX enzymes, can act as second messengers and fall in the 
same class such as other ubiquitous small-molecule messengers such as calcium ions (Ca2+)10 
and nitric oxide (NO)11. In particular, H2O2 is relatively stable with a cellular half-life of 1 ms 
and steady state levels of 10-7 M making it a suitable signaling molecule.  
 
1.1.1 NOX proteins as source of intracellular H2O2 
The first evidence that cells produce ROS in a controlled fashion was shown for the 
innate immune system, where a so-called respiratory burst produced by leucocytes results in 
pathogen killing. Identification of the NAPDH oxidase in phagosomes (phox; NOX2) of these 
cells gave evidence of a signaling-mediated activation of this enzyme and subsequent 
generation of O2-. Later homologues of the catalytic subunit gp91phox were found in other 
cell types and with different intracellular localizations, primarily in the plasma membrane 
(PM) and later also in other membranes including the nucleus, mitochondria, and the 
endoplasmic reticulum (ER)9,12. Due to their ubiquitous expression profile it became obvious 
that production of ROS is not just a side effect of aerobic life but rather a general process in 
cellular signaling controlling protein activities on any kind of level.  
So far, the NADPH oxidase (NOX) family consists of seven members; NOX1, NOX2, 
NOX3, NOX4, NOX5 and the dual oxidases DUOX1 and DUOX2, which are localized to 
various cellular membranes forming either O2- or H2O2. All members share a common 
structure, the catalytic subunit gp91phox consisting of six transmembrane domains, which 
form a channel to allow the successive transfer of electrons13. Those electrons are then 
transferred from NADPH (converting it to NADP+) to flavin adenine dinucleotide (FAD) to 
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haeme and finally to oxygen to form superoxide anions (O2-) 3. Superoxide dismutases (SODs) 
located at different intra- and extracellular compartments catalyze the dismutation from the 
superoxide radical to H2O2. The isoform SOD1 is expressed in the cytosol and the 
mitochondrial intermembrane space, SOD2 in the mitochondrial matrix and SOD3 in the 
extracellular space14,15.  
Activation of NOX enzymes is stimulus-regulated and the different NOX isoforms differ in 
their regulatory subunits. NOX1, NOX3 and NOX4 are nearly identical in size and structure 
to gp91phox/NOX2 3. Upon activation, the membrane-associated p22phox forms a mutually 
stabilizing complex with the catalytic subunit gp91phox, whose carboxyl terminus contains a 
proline-rich sequence that serves as targeting site for the two SH3 domains of the cytoplasmic 
subunit p47phox16,17. Other cytoplasmic regulatory subunits, which are getting recruited to the 
transmembrane complex, include homologue NoxO1, p40phox, p67phox and homologue 
NoxA1, and Rac1/2 depending on the NOX isoform ( 
Figure 1.1)3. The other isoforms including NOX5, DUOX1 and DUOX2 share that they are 
calcium regulated owing to EF-hand Ca2+ binding domains7. NOX1, 2, 3 and 5 produce O2- 
whereas DUOX1 and 2, and more recently discovered NOX4, are known to produce H2O2 
directly due to a peroxidase-like domain at their N-terminus7. 
 
 
Figure 1.1: Schematic representation of the activation of NOX2 in phagocytes 
Activation of NOX2 in phagocytes occurs upon assembly of the cytosolic regulatory proteins (p40phox, 
p47phox, p67phox) with the transmembrane domain flavocytochrome b558 (gp91phox and p22phox). In 
addition, Rac-GTP, which is masked by RhoGDI in its GDP-bound state, associates with the membrane and 
p67phox, stabilizing the active NOX complex. (adapted from3) 
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Various subcellular localizations of NOX1 have been reported including the nuclear 
membrane18, PM distribution19 and expression in early endosomes20. NOX2 is the most 
intensively studied isoform and is expressed in various cell types including neutrophils, where 
it was discovered first. Its subcellular localization is mostly restricted to the PM with a high 
accumulation in protrusions and membrane ruffles21,22. NOX4 has a unique role among the 
NOX family members. In contrast to the other NOX isoforms, it only requires the membrane 
subunit phox22 for its superoxide-producing activity and appears to be constitutively 
active17,23. This suggests that its activity is proportional its to protein expression alone. In 
addition, most studies report that NOX4 is solely expressed in the endoplasmic reticulum 
(ER) independent of the investigated cell type24.  
1.1.2 Compartmentalization of H2O2 
Among the different ROS, H2O2 seems to be the most promising species in mediating 
physiological relevant signaling activities. It was shown that it gets produced upon several 
growth-related stimuli including platelet-derived growth factor (PDGF)25 and EGF 
stimulation26, which activate NOX proteins via Ras and PI3K. However, it is still not fully 
understood how H2O2 concentrations can exceed normal intracellular levels needed for 
oxidative protein modifications, while the cell is packed with antioxidant enzymes.  
Two mechanisms have been discovered, which are initiated by GF stimulation. In 
contrast to other ROS, H2O2 detoxification occurs mainly through the highly abundant PRXs, 
whereat the human PRX2 shows a reaction rate of ~107 M-1s-1 with H2O227,28 compared to a 
rate constant of ~20 M-1s-1 for other thiols29. Thus, spatially confined inactivation of PRXs 
would serve as effective strategy for compartmentalized H2O2 accumulation. Indeed, it was 
shown that the membrane-associated PRX1 gets phosphorylated in a Src-dependent manner 
upon PDGF and EGF stimulation resulting in its local inactivation30. This enables H2O2 
concentrations above the threshold required to selectively oxidize target molecules near the 
PM. Another strategy, which allows spatially restricted accumulation of H2O2, was found in 
context with PRX2. In contrast to other proteins, PRX2 is easily hyperoxidized leading to the 
inhibition of this enzyme and providing a ‘floodgate’ permitting H2O2 mediated signaling 
activities (Figure 1.2)2,31. So one of the first targets of H2O2 are its own inhibitors, allowing a 
fast and confined accumulation of H2O2 at the PM. 
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Figure 1.2: Accumulation of H2O2 at the PM upon GF stimulation 
RTK activation by GF leads to superoxide (O2-) production with subsequent dismutation to H2O2 by SOD. H2O2 
can pass the cellular membrane by diffusion or via aquaporins. RTK activation leads in turn to PRDX1 
phosphorylation and inactivation, decreasing the redox-buffering capacity near the PM. An increase in H2O2 
concentrations can inactivate PRDX2 by overoxidation. These regulatory mechanisms promote the confined 
accumulation of H2O2 near the PM. (adapted from2) 
Another paradigm for local H2O2 signaling is given by the fact that NOX enzymes, 
when expressed at the PM, produce O2- and subsequently H2O2 in the extracellular space and 
not directly in the cytoplasm. This seems ineffective when intracellular target molecules 
should be reached. H2O2 is thought to freely cross membranes by diffusion thereby having the 
ability to reach back to the producing cell in an autocrine loop. In addition, it was found that 
specialized aquaporins facilitate the uptake of H2O2 into cells providing another layer of 
controlled accumulation close to the PM32,33. 
Compartmentalized production of H2O2 is also thought to occur through the 
formation of redox-active endosomes, so-called ‘redoxosomes’34. Similarly to ROS signaling, 
endosome signaling is a fairly new concept since endocytosis of proteins was long thought to 
be solely a mechanism facilitating the shut down of signaling activities. However, the mobility 
of endosomes can offer new spatial platforms for signaling events, recruitment of specific 
proteins can transduce an incoming signal to new targets and their unique geometry can 
influence protein activities35,36. When NOX proteins are expressed in endosomes, H2O2 gets no 
longer produced outside of the cell but rather inside of those specialized vesicles creating high 
local concentrations needed for oxidative protein modifications. In summary, 
compartmentalization of ROS is a prerequisite for its signaling activity and in addition one of 
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the main determinants ensuring signaling specificity. Restraining the action radius of an 
oxidant to the localization of its target molecule can thereby generate local activity patterns of 
proteins.  
1.1.3 Protein oxidative modifications 
1.1.3.1 Oxidation of protein thiols 
As already discussed above, one of the first H2O2 targets are the highly reactive 
antioxidants PRX1 and PRX2 ensuring localized accumulation of high H2O2 concentrations 
needed to oxidize less reactive target molecules27. In general, H2O2 shows high reactivity with 
cysteine (Cys) residues, oxidizing the thiol (-SH) side chain of this amino acid to sulfenic acid 
(-SOH). However, not every cysteine shows the same susceptibility towards oxidation. The 
pKa value of the target cysteine needs to be lower than the physiological pH value (pH 7.4), 
which changes the thiol group to a redox reactive thiolate anion (-S-)37. The pKa value of a 
given cysteine residue can be lowered by many factors including hydrogen bonding, an 
adjacent basic amino acid residue, the microenvironment of the target cysteine residue or 
substrate binding37. 
The oxidation of cysteine residues starts with the formation of sulfenic acid. 
Depending on the target molecule, formation of further oxidation products is possible 
including disulfide formation (S-S), S-glutathionylation (R-SSG) or S-nitrosylation (-SNO)38. 
These secondary redox modifications are necessary to prevent further oxidation to irreversible 
states such as sulfinic (-SO2H) or sulfonic acid (-SO3H), which would cause protein 
degradation and are linked rather to oxidative stress than oxidative signaling (Figure 1.3).  
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Figure 1.3: Oxidative modifications of protein cysteines 
Cysteines with a low pKa thiol are susceptible to H2O2-mediated oxidation resulting in the formation of –SOH 
(sulfenic acid), also known as sulfenylation. This modification is either stabilized by the protein 
microenvironment or it reacts with a second thiol to form an intra- or intermolecular disulfide. When H2O2 
concentrations reach a critical level, sulfenic acid can undergo further oxidation to irreversible states like sulfinic 
or sulfonic acid.  
The formation of sulfenic acid seems to be a simple chemical modification but it can 
have dramatic effects on protein functionality. The inhibition of several phosphatases upon 
oxidation is widely accepted and will be discussed in more detail in the next chapter (1.1.3.2). 
In addition to the catalytic inactivation, oxidation of proteins can also lead to an enhancement 
of their catalytic activity as shown for the monophosphate-activated protein kinase (AMPK). 
S-glutathionylation of the AMPKα subunit caused by an increase of intracellular H2O2 levels 
leads to the activation of AMPK in an ATP-independent manner39. Recently, it was also 
shown that direct sulfenylation of a critical cysteine (Cys797) in the catalytic domain of EGFR 
increases its kinase activity40, illustrating the diverse functions of redox protein modifications 
in cellular signaling. 
 
1.1.3.2 Phosphatase oxidation 
The protein tyrosine phosphatase (PTP) superfamily comprises 38 ‘classical PTPs’, 
which are broadly classified in non-receptor and receptor PTPs, and is specialized in 
dephosphorylating tyrosine residues. In addition, 61 dual-specificity phosphatases (DUSPs) 
are known, which are characterized by the ability to dephosphorylate protein-
phosphoserine/threonine residues and phosphotyrosine residues41. The lipid phosphatase 
PTEN (Phosphatase and Tensin homolog), which dephosphorylates phosphatidylinositol 
(3,4,5)-triphosphate (PIP3), is structurally related to PTPs42. Classical PTPs, DUSPs and 
PTEN share a cysteine-based mechanism characterized by a conserved HC(X5)R motif to 
catalyze dephosphorylation, defining them as cysteine-based phosphatases (CBPs)43. This PTP 
signature motif creates a unique environment for the catalytic cysteine residue. The presence 
of a conserved arginine residue confers an unusually low pKa (4.5 and 5.5) ensuring that the 
catalytic cysteine exists as a thiolate anion (Cys-S-) at physiological pH, enabling the 
nucleophilic attack on phosphorylated substrates44. But this feature also renders the cysteine 
residue highly susceptible to oxidation, in contrast to protonated cysteine thiols (Cys-SH), 
which usually exhibit a pKa value of around 8.345. Thus, H2O2 shows a reaction rate of 
20 M-1s-1 for PTP1B, whereas it reacts very slowly with glutathione and free cysteine residues 
(2–20 M–1s–1)46. In addition, oxidant bursts are often associated with an in increase in protein 
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phosphorylation, consistent with the acceptance that PTPs are one of the main targets of ROS 
signaling47. However, the members of the PTP family differ in their intrinsic susceptibility to 
oxidation, and different types of oxidative modifications of the PTP catalytic cysteine can 
occur42. 
One of the first PTPs that has been shown to undergo reversible redox modifications 
was PTP1B. Cells that were treated with Insulin or EGF produced H2O2, which led to the 
reversible inhibition of PTP1B48,49. The structurally related PTPN2 (TCPTP) is also an 
important regulator of the insulin signaling pathway and, as PTP1B, undergoes reversible 
oxidation upon insulin stimulation50,51. Later, crystallographic analysis of PTP1B showed that 
after the formation of sulfenic acid, oxygen gets rapidly eliminated to produce an 
intramolecular cyclic sulfonamide, which protects the protein against overoxidation52. 
Reactivation of oxidized PTP1B was shown to occur mainly through the thioredoxin system, 
underlining the concept of the reversibility of PTP oxidation53. A similar mechanism exists for 
the phosphatases PTEN and CDC25c. Both enzymes contain a second cysteine in addition to 
the catalytic cysteine within their active site. Upon oxidation of the nucleophilic cysteine, a 
disulfide bond is formed with the vicinal cysteine residue, which serves as protection from a 
further irreversible oxidation54,55. The receptor PTP (RPTP) α is also susceptible to oxidation, 
forming intermolecular dimers with neighboring molecules resulting in the inhibition of the 
protein56. Interestingly, the second domain D2, which is not catalytically active, is much more 
prone to be oxidized and responsible for the dimer formation than the catalytically active 
domain D1. In addition it was shown that the recruitable SH2 domain containing PTP, SHP2, 
is oxidized in cells upon treatment with PDGF and EGF depending on a complex formation 
with the respective receptor40,45.  
In conclusion, it is now known that several PTPs are inhibited by H2O2-mediated 
oxidation and that different mechanisms have evolved to prevent further irreversible redox 
modifications. By promoting PTP inactivation, oxidation can be considered as an amplifier of 
protein phosphorylation. Novel tools for monitoring protein oxidation are giving a more 
detailed picture about physiological relevant redox modifications. However, the field is still 
vague and systemic approaches are needed to unravel the actual impact of PTP oxidation in 
cell signaling.  
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1.1.4 Detection of protein oxidation 
The implication of protein oxidation in physiological and pathophysiological cell 
signaling made the development of strategies to detect oxidative modifications essential. But 
so far, available methods for monitoring protein oxidation are not as sophisticated as for other 
posttranslational modifications such as protein phosphorylation due to the labile nature of 
sulfenic acid. Nonetheless, various strategies were developed to unravel protein oxidation in 
vitro and in vivo.  
The analysis of protein oxidation by spectroscopic methods gave great insights into 
sulfenic acid formation and the resulting structural changes of oxidized proteins but is limited 
to in vitro analysis of purified or recombinant proteins. A complicated strategy is the indirect 
detection of sulfenic acid by protection of free thiols using alkylating agents and subsequent 
conversion of sulfenic acid to a thiol or sulfonic acid57. The main drawbacks include that 
protein samples undergo extensive processing under denaturing conditions, false positive 
signals from incomplete thiol blocking and several steps of chemical manipulation of cell 
lysates58. The most promising approaches are based on the reaction of sulfenic acid with a 
chemical probe. This strategy is based on both the electrophilic and weak nucleophilic 
character of the sulphur atom making nucleophiles, electrophiles and reducing agents suitable 
for the detection58. One of the most used probes for sulfenic acid detection is the nucleophile 
5,5-dimethyl-1,3-cyclohexanedione (dimedone), which reacts in a chemoselective reaction 
with the oxidized sulfur atom (Figure 1.4 A)59. However, the resulting dimedone-derivatized 
product is not distinguishable from unmodified proteins, e.g. by SDS-PAGE gel analysis. 
Therefore, radiolabeling or mass spectrometry analysis was needed to monitor adduct 
formation. Recently, dimedone-analogues with fluorescent- or biotin-tags were developed to 
facilitate an easy biochemical detection60. But analysis of fluorescein (DCP-FL) and 
rhodamine (DCP-Rho) linked dimedone derivatives indicated a partially quenched emission 
upon –SOH binding, which can falsify results. Furthermore, bulky detection tags limit cell 
permeability and can lead to a significant bias in protein target labeling. Hence, these probes 
are rather suitable for detection of sulfenic acid in recombinant proteins or cell lysates but not 
for detection in live cells. Due to the labile and transient nature of sulfenic acid modifications, 
in situ labeling is the preferable strategy to detect endogenous protein oxidative 
modifications61. By reducing the size of the chemical tag of dimedone to a minimum, Carroll 
and colleagues developed the probe DYn-240. DYn-2 is a small alkyne-functionalized probe 
that can be coupled to any azide-functionalized reporter through a cupper-catalyzed reaction 
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known as ‘click chemistry’ (Figure 1.4 B). The same study showed that in situ incubation of 
DYn-2 is suitable for monitoring changes in protein sulfenylation upon EGF stimulation 
including oxidation of PTP1B, SHP2, PTEN and EGFR40. Another strategy for detecting 
dimedone-derivatized proteins without changing the chemical features of dimedone itself, is 
the use of an antibody raised against a synthetic hapten mimicking dimedone-modified 
cysteines62. However, immunochemical methods in general have the disadvantage of a varying 
affinity of the primary antibody to the epitope and high background staining due to the 
secondary antibody making a precise quantification difficult.  
 
 
Figure 1.4: Probes for detection of protein cysteine oxidation 
(A) Chemoselective reaction between an oxidized protein (-SOH) and dimedone results in the covalent binding 
of dimedone to the sulfur atom. (B) DYn-2, an alkyne-modified homologue of dimedone can be coupled to an 
azide-modified reporter tag (e.g. biotin or fluorescent tag) via the cupper-catalyzed click chemistry reaction. This 
approach enables downstream detection via fluorescence or enrichment for proteomic analysis.  
 
1.2 RTK-PTP reaction network 
Nearly 30 years ago, Tony Hunter and colleagues uncovered the existence of protein 
tyrosine kinases (PTKs), which led to the expansion of the new field of tyrosine 
phosphorylation and the associated signaling pathways63. PTKs play a central role in nearly 
every biological process including the regulation of development, cell motility, proliferation, 
differentiation, glucose metabolism, and apoptosis64. This work focuses on receptor tyrosine 
kinases (RTKs), a family of receptors with intrinsic kinase activity mediating the signal 
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transduction from extracellular ligands to specific cellular responses. The RTK family 
comprises more than 50 cell-surface receptors structurally characterized by three major 
domains: an extracellular domain for ligand binding, a membrane-spanning segment, and a 
cytoplasmic domain, which possesses tyrosine kinase activity and contains phosphorylation 
sites64. Phosphorylated tyrosine residues serve as docking sites for effector proteins, which 
recognize the active receptor via phosphotyrosine-binding (PTB) domains or Src-homolgy 2 
(SH2) domains65. RTK activity gets counterbalanced by PTPs, which catalyze the 
dephosphorylation of tyrosine residues and therefore initiating the shut down of signal 
transduction.  
 
1.2.1 EGFR activation and signaling 
The first growth factor discovered was the epidermal growth factor (EGF) activating 
its cognate receptor, the epidermal growth factor receptor (EGFR)66,67. EGFR belongs to the 
EGFR/ErbB family of RTKs including 4 family members; EGFR (ErbB1), ErbB2, ErbB3 and 
ErbB4. Abnormal activation of ErbB family members is found in many cancers, in fact 
making EGFR the first receptor identified as an oncogene67,68. In general, ligand binding 
induces EGFR dimerization, stabilizes the active form of the receptor and promotes the 
autophosphorylation of tyrosine residues. In addition to ligand-binding, it was shown that 
enhanced expression of the receptor can trigger the formation of ligand-free dimers, resulting 
in autonomous receptor activation found in several cancer types69.  
EGFR consists of an extracellular module (separated in domains I, II, III and IV), 
connected by a single-helix transmembrane segment and a juxtamembrane segment to an 
intracellular kinase domain followed by a long regulatory C-terminal tail70. The extracellular 
domain exists either in a closed ‘tethered’ form shielding the sites important for dimer 
formation or an ‘open’ conformation, which is primed for dimerization (Figure 1.5)71. Both 
conformations exist in the absence of ligand with a preference for the closed, autoinhibited 
conformation. Upon ligand binding, the extracellular domains of two receptors dimerize 
‘back-to-back’, which propagates to an enzymatically active kinase domain72. The extracellular 
dimer interface is solely receptor-mediated with the ligand bound on the outside (Figure 
1.5)70,73.  
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Figure 1.5: Structure of the extracellular module of EGFR 
Structural model of the ligand-induced, conformational change of the extracellular domain of EGFR. Domain I 
and III are important for ligand binding whereas domain II and IV form the dimer interface. (adapted from69) 
 
In contrast to other kinases, it is still unclear, which impact the phosphorylation of the 
activation loop in EGFR has in adopting an active kinase conformation74. So far, it was shown 
that upon activation two EGFR kinase domains interact in an asymmetric fashion, where one 
(activator) switches on the other (receiver) in an allosteric mechanism (Figure 1.6)72. 
Phosphorylation of Y845, the critical tyrosine within the kinase domain, is not necessary to 
adopt this conformation but enhances the catalytic activity of the receptor and is proposed to 
suppress the intrinsic disorder of the kinase domain75. EGF-binding favors N-terminal 
dimerization of the transmembrane domains translating in a further dimerization of the 
juxtamembrane segments, and formation of the asymmetric kinase dimer. In contrast, C-
terminal dimerization of the transmembrane helices was found in ligand-free dimers leading 
to a dissociation of the juxtamembrane segments resulting in the formation of a symmetric, 
inactive kinase dimer70,73. Upon EGF stimulation, EGFR can also form higher-order multimers 
initiated by domain IV of the extracellular module76,77. The same study also showed that 
multimerization is necessary for full autophosphorylation in trans. When EGFR only exists in 
dimers, tyrosine residues that are proximal to the kinase domain are phosphorylated just in 
one subunit76.  
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Figure 1.6: Model for monomer-dimer equilibrium of EGFR 
Scheme shows the transition of inactive monomers to an active, asymmetric dimer. In addition, other states are 
possible like ligand-free active dimers at high expression level or ligand-free inactive dimers depending on the 
structural conformation. (adapted from73) 
Once activated, the first substrate for EGFR phosphorylation is the receptor itself. 
Several tyrosine residues are getting phosphorylated including the autophosphorylation sites 
Y992, 1045, 1068, 1086 and 1173. Y992, 1068, 1086 and 1173 are generally linked to an 
activation of the Ras/MAPK and PI3K/AKT signaling pathways, while Y1045 serves as 
docking site for the E3 ubiquitinase Cbl resulting in receptor ubiquitination and 
degradation78. The tyrosine residue 845 however has a special role when it comes to EGFR 
activation. Considered as transphosphorylation site activated by Src79, structural studies 
suggest a role in stabilizing EGFR dimers, thereby promoting catalytic activation even in the 
absence of ligand75. Thus, Y845 gets described as ‘autocatalytic’ site of EGFR.  
Autocatalytic activation of EGFR enables fast and robust activation upon stimulation 
but comes with the prize of spontaneous receptor activation and the chance for spurious 
signaling. The autoinhibition facilitated by structural features of EGFR discussed above 
represents one strategy to prevent receptor activation in the absence of ligand. In addition to 
this intrinsic safeguard mechanism, it was shown that continuous recycling of spontaneous 
activated RTK molecules to the perinuclear area, which is characterized by high PTP activity, 
keeps basal receptor activation low80,81. Therefore, it is important to consider EGFR signaling 
as the sum of autocatalytic receptor activation and the recursive interaction with PTPs. 
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1.2.2 Coupling between RTK and PTP activity by ROS 
The traditional view of EGFR signaling comprises linear signaling pathways resulting 
in the transcription of a specific set of genes leading to a distinct cellular response such as 
proliferation or survival. However, several key studies have shown that the signaling pathways 
downstream of every RTK are highly interconnected representing a complicated signaling 
network with the receptor as conserved processing core82,83. Therefore, EGFR signaling should 
be understand as an integrated system, in which specificity is determined by the spatial-
temporal dynamics of activation of signaling proteins84. For instance, feedforward and 
feedback loops embracing interacting EGFR pathways make the input–output response of one 
pathway dependent on the activity of the other pathway, thereby creating a context-dependent 
signaling output84,85. The interaction of EGFR with PTPs plays in this context an important 
role. By dephosphorylating the receptor itself or different downstream molecules, PTP activity 
is one of the major determinants in shaping the dynamic behaviour of RTK signaling, 
converting a transient or sustained growth factor activation into distinct responses, such as all 
or none, oscillatory, and pulsatory responses84.  
RTK and PTP activity show at any time a tight interplay. For instance, it was shown 
that inhibition of PTP activity leads to autonomous EGFR activation indicating that even at 
basal level, receptor phosphorylation is the result of a continuous cycle of phosphorylation 
and dephosphorylation86-88. When stimulated with EGF, receptor phosphorylation displays 
hysteresis, meaning that the stimulus needs to exceed a threshold value to flip the system from 
a low to high activity state, which may even remain when the stimulus returns to its initial 
value84. This is in general the property of a bistable system, which is created here by the 
coupling of RTK activity to PTP inhibition through the production of H2O226,86. In general, a 
bistable system can switch between two distinct stable states, but cannot rest in intermediate 
states89. In the time course of ligand stimulation, EGFR gets dephosphorylated when 
internalized showing that intracellular PTP activity has to overcome RTK activity. This is 
ensured through a spatial partitioning of RTK and PTP activity with PTP activity peaking 
around the perinuclear area generating a robust EGFR activation at the PM and shut down of 
the signal upon internalization90. 
EGFR activation leads to H2O2 production by activating NOX complexes at the PM. 
The phosphorylated receptor recruits the adapter protein Grb291, which leads to activation of 
the Ras/MAPK pathway. Active Ras in turn activates the guanine nucleotide exchange factor 
(GEF) Tiam1 important for the conversion of GDP-bound Rac1 into the active GTP-bound 
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form, a subunit of NOX1, NOX2 and NOX392. Rac activation can also be catalyzed by other 
GEFs including Son of sevenless (SOS), Vav or Pix depending on the activated RTK and NOX 
isoform. For EGFR it was shown that βPIX activation by PI3K is important for Rac activation 
and NOX1 mediated H2O2 production93. In addition, active PI3K catalyzes the 
phosphorylation of phosphatidylinositol (4,5)-biphosphate (PIP2) to phosphatidylinositol 
(3,4,5)-triphosphate (PIP3). The NOX subunit p47phox binds to PIP3 via its PH domain after 
the release of an autoinhibitory structural conformation. It was shown that serine/threonine 
phosphorylation catalyzed by AKT and PKC are crucial for p47phox recruitment to the 
membrane and full assembly of the NOX complex16. As a consequence, H2O2  can accumulate 
near the PM inactivating PTPs and thereby promoting full EGFR activation. Hence, 
autocatalytic activation of EGFR and inhibition of PTPs upon EGF binding leads to a shift in 
the kinase-phosphatase balance in favour of the kinase allowing signal transduction94.  
Depending on the network architecture either lateral propagation of a stimulus or 
distinct pattering can be generated, illustrating the extremely rich repertoire of different 
dynamic behaviours of EGFR signaling (Figure 1.7). The emergence of large-scale patterns 
from random local fluctuations was already proposed by Turing in 195295. Recently, it was 
shown that a similar mechanism is used to keep the mean amount of phosphorylated EGFR 
per endosome constant, even forming distinct activity clusters96. The authors proposed that 
the phosphatase SHP2 gets recruited to active EGFR on endosomes where EGFR activates 
SHP2 by phosphorylation promoting its own dephosphorylation in a negative feedback loop. 
This strategy could be one aspect of the analogue-to-digital conversion of RTK signaling, 
necessary to elicit distinct cellular responses out of continuous variables like extracellular 
growth factor concentrations. In addition, it illustrates how the causality of the RTK-PTP 
network shapes RTK response properties enabling the formation of different activity patterns. 
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Figure 1.7: RTK-PTP network topologies determine RTK activity pattern 
(A) Double negative feedback as generated by RTK-mediated H2O2 production leads to a bistable system. RTK 
density on the membrane determines spreading of RTK activity either leading to lateral signal propagation 
(upper case) or signal termination (lower case) after local point activation. (B) A Turing system as generated by a 
RTK that activates its own inhibitory PTP leads to RTK activity spots at high receptor density (upper case) after 
global stimulation. (adapted from94) 
 
1.3 ROS and cancer 
Elevated ROS level are a common phenomenon in cancer and other pathologies. Two 
decades ago it was found that cancer cells generate higher levels of ROS than their non-
transformed counterparts, raising the question if redox signaling has an impact in disease 
initiation and progression97.  
Indeed, several reports support the theory that ROS production and signaling promote 
transformation of malignant cells. For instance, it was shown that human cancer cells driven 
by oncogenic KRas require mitochondrial ROS for proliferation98. In addition, NOX1 itself is 
capable of transforming NIH3T3 cells, and when injected into nude mice these cells produce 
particularly aggressive tumors9. On the other hand, YA cell line transformation was reserved 
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by co-transfection with catalase, providing strong evidence for a role of H2O2 in cellular 
transformation and growth99. 
The tight coupling between ROS and cancer is also reinforced by the observation that 
many common oncogenes such as Ras can directly alter the redox state of a cell100. At the same 
time, it was shown that cells with increased ROS levels are dependent on a more potent 
antioxidant system to prevent senescence (Figure 1.8)101. Signaling motifs that are responsive 
to H2O2 are localized close to the sources of ROS generation, allowing activation of those 
despite the high overall antioxidant activity in cancer cells that protects against oxidative-
stress-induced cell death102. A classical example of this strategy is the oxidation of the 
phosphatase PTEN at the PM, activating the pro-survival pathway via PI3K and AKT54. In 
turn, it was shown that PRDX1, a ROS scavenger, expression reactivates oxidized PTEN 
restoring its tumor suppressive function103. As already discussed earlier, the crosstalk between 
RTK activation and ROS signaling leads to the reversible inhibition of PTPs. Increased H2O2 
levels in cancer cells can therefore lead to an enhanced inhibition of PTPs thereby promoting 
kinase-dependent signaling driving cancer formation104.  
The impact of ROS in malignant signaling makes it also an interesting target for the 
development of new anti-cancer treatments. In general, two strategies can be distinguished; 
either the application of drugs decreasing intracellular ROS levels or treatments, which lead to 
the further increase of ROS until the cellular antioxidant system is saturated provoking cell 
death.  The former option seemed promising as inhibition of tumorigenesis was shown upon 
treatment with antioxidants such as n-acetylcysteine (NAC) and vitamin C105. But several 
large-scale, clinical studies have shown that dietary antioxidant supplementation with β-
carotene, vitamin A or vitamin E rather increased cancer progression than preventing it106,107. 
These conflicting results illustrate the fragile nature of redox homeostasis and that 
perturbations of this system have in most cases an unpredictable outcome. The opposite 
approach of increasing ROS levels till cancer cells can no longer cope with them implies that 
cancer cells are more vulnerable to oxidative stress-induced cell death. Indeed, treatment of 
cultured human colorectal cancer (CRC) cells harbouring KRas or BRaf mutations with high 
levels of vitamin C leads to the depletion of the antioxidant glutathione (GSH). Thus, ROS 
accumulates leading to the inactivation of GAPDH resulting in an energetic crisis and cell 
death108. Moreover, administration of the small molecule piperlongumine has been shown to 
decrease the abundance of reduced GSH leading to a selective killing of cancer cells109. Several 
similar approaches were successful in inhibiting cancer cell growth making a combination of 
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ROS-producing agents with ROS-scavengers beneficial for clinical cancer therapy110. A better 
understanding of the molecular mechanisms of ROS signaling in cancer cells could help to 
identify pathways that are indispensable for cancer cell survival. Targeting these mechanism 
could help to reduce cancer cell adaptation and resistance to common chemotherapeutics83.  
 
 
 
Figure 1.8: Interdependence between ROS levels and cancer 
Moderate levels of ROS (yellow) can promote cell proliferation or survival pathways, whereas abnormally high 
concentrations result in oxidative stress causing senescence or cell death (purple). Adaptive mechanisms in 
cancer cells can counter oxidative stress enabling cell survival (blue). However, these adaptions make cancer cells 
more prone to apoptosis caused by a further increase in ROS levels. (adapted from111) 
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2 Objective 
The delicate balance between protein phosphorylation and dephosphorylation is a 
major determinant in regulating protein activity in signaling networks. Imbalances in these 
processes are frequently linked to malignant transformation and tumor development. In 
general, PTPs catalyze the dephosphorylation of signaling proteins, mostly important for 
shutting down signaling activity initiated by tyrosine kinases such as RTKs. The interplay 
between PTPs and RTKs is shaping the spatial-temporal distribution of phosphorylated 
proteins in cells, thereby determining cell fate.  
In the last years, inactivation of PTPs by H2O2 has gained more interest and opened up 
a new field of discussion about the link between RTK activity and PTP inhibition. This 
coupling between RTK activation and PTP inhibition is ensured by activation of NADPH 
oxidases downstream of active RTKs, such as EGFR. The production of H2O2 and the 
resulting inhibition of PTPs together with the autocatalytic activity of EGFR generates a 
bistable system86,112. Thereby, receptors retain low activity in unstimulated cells and show a 
robust response to a certain threshold concentration of ligand.  
In this work, we want to investigate if the malignant transformation of cells by HRas 
G12V increases intracellular H2O2 levels as often observed in human tumors. Furthermore, we 
want to investigate if oncogene-induced H2O2 is affecting the EGFR-PTP network by 
inhibiting the overall PTP activity and thus lowering the EGFR activation threshold. 
Therefore, we want to monitor the H2O2 production in transformed and non-transformed 
cells and how it can affect EGFR phosphorylation dynamics at basal level and upon ligand 
stimulation. Furthermore, it is still difficult to detect protein oxidation in living cells. By 
implementing a new approach, we want to reveal PTP oxidation with spatial-temporal 
resolution in the context of malignant transformation induced by HRas G12V. In summary, 
this should give new insights into the RTK-PTP reaction network, their coupling through 
H2O2 and how this network is affected upon oncogenic transformation of cells.  
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3 MATERIALS AND METHODS 
3.1 Materials 
3.1.1 Chemicals 
2-Mercapto-ethanol SERVA Electrophoresis GmbH 
Acetic acid Sigma-Aldrich 
Ammonium persulfate (APS) SERVA Electrophoresis GmbH 
Ampicillin sodium salt SERVA Electrophoresis GmbH 
Bromophenolblue Sigma-Aldrich 
Catalase Sigma-Aldrich 
Copper(II) Sulfate (CuSO4) Sigma-Aldrich 
DCP-Bio1 Kerafast, Inc. 
DCP-Rho1 Kerafast, Inc. 
Dimedone Sigma-Aldrich 
Dimethyl sulfoxide (DMSO) SERVA Electrophoresis GmbH 
Dithiothreitol (DTT) Fluka Analytical 
DYn-2 Cayman Chemical 
Ethanol J.T.Baker 
Ethylenediaminetetracetic acid (EDTA) Fluka® Analytical 
Glycerol GERBU Biotechnik GmbH 
Hoechst 33342 Thermo Fisher Scientific 
Isopropanol J.T.Baker 
Kanamycin sulfate GERBU Biotechnik GmbH 
Magnesium chloride (MgCl2) Merck KG/J.T.Baker 
Methanol AppliChem GmbH 
Monopotassium phosphate (KH2PO4) J.T.Baker 
N-Ethylmaleimide (NEM) Sigma-Aldrich 
N,N,N’,N’-Tetramethylene-diamine (TEMED) Sigma-Aldrich 
Sodium chloride (NaCl) Fluka Analytical 
Sodium dodecyl sulfate (SDS) SERVA Electrophoresis GmbH 
Tris-base Carl Roth GmbH 
Tris-HCl J.T.Baker 
Tris(2-carboxyethyl)phosphin (TCEP) Sigma-Aldrich 
Tris(benzyltriazolylmethyl)amine (TBTA) Carl Roth GmbH 
Tritox X-100 SERVA Electrophoresis GmbH 
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Tween 20 SERVA Electrophoresis GmbH 
UltraPure™ Agarose Thermo Fisher Scientific 
 
3.1.2 Enzymes 
AgeI-HF (10,000 U/ml) New England Biolabs Inc. 
Calf Intestinal Phosphatase (10,000 U/ml) New England Biolabs Inc. 
HindIII-HF (20,000 U/ml) New England Biolabs Inc. 
NheI-HF (20,000 U/ml) New England Biolabs Inc. 
T4-DNA ligase  Thermo Fisher Scientific 
XhoI (20,000 U/ml) New England Biolabs Inc. 
 
3.1.3 Antibodies 
Primary Antibodies Source Supplier 
Actin Mouse Mab1522, Chemicon 
Akt  Mouse 2920, Cell Signaling Technology 
Akt (pThr308) Rabbit 9271, Cell Signaling Technology 
Cysteine sulfenic acid Rabbit 07-2139, Millipore 
EGFR Goat AF231, R&D Systems 
EGFR Rabbit 4267, Cell Signaling Technology 
EGFR (pY1045) Rabbit 2237, Cell Signaling Technology 
EGFR (pY1068) Rabbit 3777, Cell Signaling Technology 
EGFR (pY845) Mouse 558381, BD Bioscience 
Erk  Mouse ab36991, Abcam 
Erk (pThr202/pThr204) Rabbit 9101, Cell Signaling Technology 
GAPDH  Mouse Cb1001, Calbiochem 
GAPDH Rabbit 14C10, Cell Signaling Technology 
GFP Mouse 632681, Clontech 
GFP  Rabbit 632593, Clontech 
NOX2 Rabbit ab31092, Abcam 
NOX4 Rabbit ab79971, Abcam 
Phosphotyrosine (PY72) Mouse InVivo Biotech Services GMBH 
PTP1B Mouse 610139, BD Bioscience 
α-tubulin Mouse T9026, Sigma-Aldrich 
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Secondary Antibodies Supplier 
Alexa Fluor 488 donkey anti-rabbit Invitrogen™ Life Technologies 
Alexa Fluor 546 goat anti-mouse Invitrogen™ Life Technologies 
Alexa Fluor 555 donkey anti-goat Invitrogen™ Life Technologies 
Alexa Fluor 647 chicken anti-rabbit Invitrogen™ Life Technologies 
Alexa Fluor 647 donkey anti-mouse Invitrogen™ Life Technologies 
IRdye 680 donkey anti-goat LI-COR® Biosciences 
IRdye 680 donkey anti-mouse LI-COR® Biosciences 
IRdye 680 donkey anti-rabbit LI-COR® Biosciences 
IRdye 800 donkey anti-goat LI-COR® Biosciences 
IRdye 800 donkey anti-mouse LI-COR® Biosciences 
IRdye 800 donkey anti-rabbit LI-COR® Biosciences 
 
3.1.4 Oligonucleotides 
All oligonucleotides were purchased from MWG Eurofins as unmodified DNA Oligos. 
 
HyPer-ER_LIC-F GATAAAGTTTTAAAACAGGCGGTTCATGCACTGAGTTACTGG 
HyPer-ER_LIC-R GTTCAACAGCAACACAATGATGCAGTCGACGGTACCGC 
 
3.1.5 Plasmids 
cHyPer3 kind gift by Vsevolod V. Belousov (NBIC, Moscow, Russia) 
EGFR-mCherry ErbB1 with C-terminally fused mCherry (cloned by Jenny Ibach) 
EGFR-mCitrine ErbB1 with C-terminally fused mCitrine (cloned by Jenny Ibach) 
HyPer3-ER generated by fusing the ER coding sequence from PTP1B with cHyPer3 
HyPer3-TK generated by fusing the CAAX box from KRas with cHyPer3 (cloned by 
Lisaweta Roßmannek) 
mCherry-N1 Clontech Laboratories Inc. 
PTB-mCherry PTB domain from Shc with C-terminal mCherry (cloned by Jenny 
Ibach) 
 
3.1.6 Kits and Commercial Solutions 
3.1.6.1 Molecular Biology 
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100x BSA New England Biolabs Inc. 
10x Restriction Enzyme Buffer 1-4 New England Biolabs Inc. 
2-log DNA ladder New England Biolabs Inc. 
5x T4 DNA Ligation Buffer Thermo Fisher Scientific 
BigDye® Terminator v3.1 cycle sequencing kit Applied Biosystems 
DyeEx® 2.0 Spin kit QIAGEN 
NucleoBond® Xtra Maxi EF kit Macherey-Nagel GmbH & Co. KG. 
NucleoSEQ Macherey-Nagel GmbH & Co. KG. 
QIAprep® Spin Miniprep kit QIAGEN 
QIAquick® Gel Extraction kit QIAGEN 
RedSafe nucleic acid staining solution iNtRON 
Roti®-Histofix 4 % Carl Roth GmbH 
Roti®-Prep Plasmid MINI Carl Roth GmbH 
 
3.1.6.2 Cell Culture 
Dulbecco’s Modified Eagle’s Medium (DMEM) PAN™ Biotech 
Dulbecco’s Phosphate Buffered Saline (DPBS) PAN™ Biotech 
Fetal bovine serum (FBS) PAN™ Biotech 
FuGENE® HD Transfection Reagent Promega 
Hank’s Buffered Salt Solution (HBSS) PAN™ Biotech 
L-Glutamine PAN™ Biotech 
Lipofectamine® Transfection Reagent Thermo Fisher Scientific 
Non-essential amino acids 100x PAN™ Biotech 
Trypsin/EDTA Macherey-Nagel GmbH & Co. KG. 
3.1.6.3 Biochemistry 
30 % Acrylamide/Bis solution Bio-Rad Laboratories, Inc. 
30 % Hydrogen Peroxide (w/w) in H2O  
Alexa Fluor® 594 Azide Thermo Fisher Scientific 
Amicon 30 kD cut-off Protein Desalting Spin 
Columns 
Thermo Fisher Scientific 
Bradford reagent Sigma-Aldrich® 
Chameleon Duo Pre-Stained Protein Ladder Li-Cor® Biosciences GmbH 
Complete Mini EDTA-free protease inhibitor tablets Roche Applied Science 
Fluorolink Cy3.5 Monofunctional Dye GE Healthcare 
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Image-iT FX Signal Enhancer Thermo Fisher Scientific 
Novex NuPAGE LDS-Sample Buffer 4x Thermo Fisher Scientific 
NuPAGE® Antioxidant Thermo Fisher Scientific 
NuPAGE® LDS Sample Buffer (4X) Thermo Fisher Scientific 
NuPAGE® MES SDS Running Buffer (20X) Thermo Fisher Scientific 
NuPAGE® MOPS SDS Running Buffer (20X) Thermo Fisher Scientific 
Odyssey Infrared Imaging System blocking buffer LI-COR Biosciences GmbH 
PF6-AM friendly provided by Chang lab, University of 
California, Berkeley, California 
PG-Sepharose beads Sigma-Aldrich® 
Phos-Tag Biotin BTL-104 Wako Pure Chemicals Industries 
Phosphatase Inhibitor Cocktail 2 Sigma-Aldrich® 
Phosphatase Inhibitor Cocktail 3 Sigma-Aldrich® 
Precision Plus ProteinTM Dual Color Prestained 
standards 
Bio-Rad Laboratories, Inc. 
Streptavidin Sigma-Aldrich® 
XT Reducing Agent 20x Bio-Rad Laboratories, Inc. 
XT Sample Buffer 4x Bio-Rad Laboratories, Inc. 
Zeba Spin Desalting Columns 40k MWCO Thermo Fisher Scientific 
 
3.1.7 Buffers and Solutions 
3.1.7.1 Molecular Biology 
1x TAE 40 mM Tris/Acetate (pH 7.5), 20 mM NaOAc, 1 mM EDTA 
2-log DNA ladder 1 mg/ml 2-log DNA ladder (NEB) diluted in 1x DNA loading buffer (50 
µg/ml) 
DNA loading buffer 50% glycerol, 0.1% Orange G, 0.1 M EDTA 
LB agar 15 g/l agar in LB medium  
(ZE Biotechnologie, MPI Dortmund) 
LB medium 10 g/l Bacto-Trypton, 5 g/l yeast extract, 10 g/l NaCl, pH7.4 
SOC medium 20 g/l Bacto-Trypton, 5 g/l Bacto yeast extract, 0.5 g/l NaCl, 2.5 mM KCl, 
10 mM MgCl2, 20 mM glucose (ZE Biotechnologie, MPI Dortmund) 
 
3.1.7.2 Cell Culture 
Complete Growth DMEM + 10 % FBS, 1 % NEAA and 2 mM L-Glutamine in DMEM  
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Medium (CGM) 
Imaging medium DMEM without Phenol red + 25 mM HEPES + 0.5 % FBS 
Starvation Medium DMEM + 0.5 % FBS, 1 % NEAA and 2 mM L-Glutamine in DMEM 
 
3.1.7.3 Biochemistry 
1x TBS 100 mM Tris-HCl, 150 mM NaCl 
1x TBS (PhosTag) 10 mM Tris, 100 mM NaCl, pH adjusted to 7.5 
1x TBS-T 100 mM Tris-HCl, 150 mM NaCl, 0.1 % Tween®-20 
1x TBS/T (PhosTag) 1x TBS, 0.1 % Tween®-20 
Dimedone lysis buffer 50 mM Tris (pH 8), 150 mM NaCl, 1 % IGEPAL, 0.1 mM PMSF, 20 mM 
NEM 
Modified RIPA lysis 
buffer 
50 mM triethanolamine hydrochloride (pH 7.4), 150 mM NaCl, 1 % 
IGEPAL, 1 % Na deoxycholate, 0.1 % SDS, 200 U/ml Catalase 
RIPA lysis buffer 50 mM Tris (pH 7.5), 150 mM NaCl, 1 mM EGTA, 1 mM EDTA, 1% 
IGEPAL, 0.25% Na-deoxycholate, 2.5 mM Na pyrophosphate, 1 mM β-
glycerophosphate, 0.1 mM PMSF 
SDS Running buffer, 10x 25 mM Tris-base, 192mM glycine, 0,1% SDS 
 
SDS Sample buffer, 5x 60 mM Tris-HCl (pH 6.8), 25 % glycerol, 2 % SDS, 14.4 
mM 2-mercapto-ethanol, 0.1 % bromo-phenolblue 
Transfer buffer, 10x 25 mM Tris-base, 192mM glycine, 20% methanol 
 
3.1.8 Mammalian Cell Lines 
3.1.9 Ligands, Proteins and Inhibitors 
DPI Sigma-Aldrich 
EGF-AlexaFluor647 Kirsten Michel 
EGF, human Sigma-Aldrich 
PalmB Nachiket Vartak 
PTP1Bc Jian Hou 
3.1.10 Material and Equipment 
1.5 mm 10-well, 12-well, 15-well combs Thermo Fisher Scientfic 
35-mm MatTek petri dishes MatTek Corporation 
4-well LabTek chambers Nunc by Thermo Fischer 
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8-well LabTek chambers Nunc by Thermo Fischer 
BioRad ChemiDocTM XRS Bio-Rad Laboratories, Inc. 
BioRad Power Pac HC  Bio-Rad Laboratories, Inc. 
Cell scraper 16cm 2-Pos.-blade Sarstedt AG and Co. 
Centrifuge 5415R Eppendorf 
Centrifuge 5810R Eppendorf 
Centrifuge RC 26 Plus  Sorvall 
Cuvettes (1 ml) Ref. 67.742 Sarstedt Aktiengesellschaft & Co. 
ddH2O Millipore 
Dual Plate xCELLigence Roche Applied Science 
Empty Gel Cassettes, mini, 1.5 mm Thermo Fisher Scientfic 
Eppendorf safe lock tubes (0.5/1.5/2 ml Eppendorf 
Falcon tubes (15/50 ml)  BD FalconTM 
Heatable magnetic stirrer ‘IKMAG®RCT’ IKA®Labortechnik 
Incubation box for western blots LI-COR Biosciences 
Mini and Midi agarose gel chamber Carl Roth GmbH 
Molecular Imager Gel Doc XR Bio-Rad Laboratories 
NALGENE® Cryo 1 °C freezing container Nunc by Thermo Fischer 
Nanodrop ND-1000 spectrophotometer Peqlab Biotechnologie GmbH 
NuaireTM Cellgard Class II Biological Safety Cabinet 
Integra Biosciences 
Integra Biosciences 
NuPage 4-12% Bis-Tris Gel Novex by Life Technologies 
Odyssey Infrared Imager Licor Biosciences 
Parafilm  Pechiney Plastic Packaging 
Pipetboy acu Integra Biosciences 
PVDF membrane Bio-Rad Laboratories, Inc. 
Sarstedt serological pipettes (5/10/25 ml) Sarstedt AG & Co. 
T25 tissue culture flask Sarstedt AG and Co. 
T75 tissue culture flask Sarstedt AG and Co. 
Test tube rotator 34528 Snijders 
Tissue culture plates (24-well) Sarstedt AG and Co. 
Tissue culture plates (6-well)  Sarstedt AG and Co. 
Vacuum centrifuge Eppendorf 
Vi-CellTM XR cell viability analyzer Beckman Coulter, Inc. 
Vortex Genie I touch mixer Scientific Industries 
XCell IITM Blot Module  InvitrogenTM Life Technologies 
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XCell SureLockTM Mini-Cell Electrophoresis System InvitrogenTM Life Technologies 
3.1.11 Microscopes 
Cell R Olympus 
Fiber coupling unit PicoQuant GmbH 
Fluo View FV1000 Olympus 
HCX PL APO (λ blue) 63x/1.4 Leica MICROSYSTEMS 
HCX PL APO 40x/1.25- 0.75 Leica MICROSYSTEMS 
HCX PL APO CS2 63x/1.4 Leica MICROSYSTEMS 
IU-LH75XEAPO: 75W xenon APO lamp Olympus 
IX 81: inverse microscope Olympus 
IX2-UCB controlling unit Olympus 
Leica TCS SP5  Leica MICROSYSTEMS 
Leica TCS SP8 Leica MICROSYSTEMS 
PR-IX2 motorised stage Olympus 
Scan Stage Olympus 
Sepia II PicoQuant GmbH 
U-HSTR2: hand switch Olympus 
U-RFL-T Olympus 
UPLSAPO 40x/0.9 NA Olympus 
UPLSAPO 60x/1.2 NA Olympus 
 
3.1.12 Software 
Adobe Illustrator CS4 Adobe Systems Inc. 
CellProfiler CellProfiler 
Fiji  Schindelin et al. Nat. Meth. (2012) 
FV10-ASW Fluoview Software Olympus 
Igor Pro v6.35A5 Wavemetrics 
ImageJ64 v1.48i http://imagej.nih.gov/ 
Leica Application Suite Leica 
MatLab MathWorks 
Microsoft Office 2011 Microsoft Corporation 
Prism 6 GraphPad Software, Inc. 
RTCA Software v2.0 ACEA Bioscience, Inc. 
SymPhoTime v5.12 Picoquant GmbH 
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3.2 Methods 
3.2.1 Molecular Biology 
3.2.1.1 Transformation of chemically competent bacteria 
For amplifying recombinant DNA, chemically competent E.coli cells (XL 10 Gold) 
were transformed with foreign plasmid DNA. For each transformation, 1.63 µl 2.25 mM DTT 
and either ligation product (5 µl) or plasmid DNA (~50 ng) was added to 50 µl bacteria. Cells 
were incubated on ice for 30 min, followed by a heat shock at 42°C for 90 sec; cells were then 
returned on ice for another 2 min. For expressing the antibiotic resistance, encoded on the 
plasmid, 250 µl SOC medium was added and cells were incubated for 1 hour at 37°C and 225 
rpm. The bacteria were shortly centrifuged and supernatant was discarded by decanting. For 
transformation of ligation product, the whole pellet was resuspended and plated on LB agar 
plates containing the appropriate antibiotics (50 µg/ml Kanamycin or 100 µg/ml Ampicillin). 
If plasmid DNA was transformed, 20 – 50 µl of the cell suspension was plated. The plates were 
incubated overnight at 37°C. 
On the next day, single colonies were picked and grown at 37°C and 225 rpm in 5 ml 
LB medium supplemented with appropriate antibiotic. Either the bacteria were grown 
overnight (mini cultures) or the preculture was transferred to 150 ml LB medium 
supplemented with antibiotic after 6 hours (midi cultures) and incubated at 37°C overnight. 
Mini cultures were used for further DNA manipulations and midi cultures were used to 
obtain endotoxin-free plasmids for transfection of mammalian cell cultures. 
3.2.1.2 Agarose gel electrophoresis 
To separate nucleic acids by size, agarose gel electrophoresis was used. The DNA was 
separated in 0.8 % to 2.0 % agarose gels depending on the size of the DNA molecules in 
question. Agarose gels were prepared with TAE buffer supplemented with 5 µl/100 ml 
RedSafeTM DNA stain. For size estimation of DNA fragments, a 2-log DNA ladder was added 
to one lane of the gel. Samples were diluted in either 6X loading buffer (Novagen) or 10X 
loading buffer based on Orange G. If a separated DNA fragment was needed for further 
cloning the desired band was cut out of the gel and the DNA was purified with the QIAquick® 
Gel Extraction Kit (Quiagen) as described in the manufacturer’s manual. 
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3.2.1.3 Restriction Digest 
Restriction Endonucleases Type II are cutting double-stranded DNA at specific 
nucleotide sequences, so called restriction sites. This method was used for analyzing cloning 
products, for creating linearized DNA vectors and DNA fragments with sticky ends for 
ligation. 
Each restriction reaction was carried out with 1 – 2 µg DNA, 10 U of each restriction 
enzyme (New England Biolabs, Inc.) and the appropriate buffer. The reaction was replenished 
with ddH2O to a final volume of 100 µl. For a complete digestion, reactions were incubated for 
1 h up to overnight at 37°C. Linearized plasmids or PCR products were purified using the 
QIAquick® PCR purification kit (Quiagen) or extracted after agarose gel electrophoresis using 
QIAquick® Gel Extraction Kit. 
3.2.1.4 Dephosphorylation of 5’-Phosphorylated DNA fragments 
To prevent self-ligation of the destination vector, dephosphorylation of 5’-end of the 
cut vector needs to be carried out. Therefore, 0.5 U/µg DNA of alkaline phosphatase (calf 
intestinal phosphatase, CIP) was added directly on the restriction mix and reaction tubes were 
incubated for 1 h at 37 °C. 
3.2.1.5 Ligation of DNA fragments 
To create the desired cloning product out of a linearized vector and a specific insert, 
DNA ligation reaction was used. The T4 DNA ligase (New England Biolabs, Inc.) catalyzes the 
formation of two covalent phosphodiester bonds between the 3' hydroxyl end of one 
nucleotide with the 5' phosphate end of another nucleotide under consumption of ATP. 
Usually 50 ng of a vector were used with a threefold molar excess of insert fragments. The 
ratio between vector and insert has been adjusted if the insert size was much smaller in 
relation to the vector. The following formula was used to calculate the necessary amount of 
insert: 
 
amount insert [ng]  =   amount vector   ng  ∙ insert size [bp]  ∙ excess insertvector size [bp]  
 
The reaction was supplemented with the provided reaction buffer, T4 DNA ligase and 
replenished with ddH2O to 20 µl. The incubation was carried out for 1 hour at RT or at 16°C 
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overnight. The ligation reaction was subsequently used for transformation into chemically 
competent bacteria (3.2.1.1). 
 
3.2.1.6 Ligation independent cloning 
The desired insert was amplified via PCR with AccuPrimeTM Pfx. Next, the destination 
vector was linearized using appropriate digestion enzymes and 5’ overhang was created with 
T4 DNA polymerase (NEB). The annealing was carried out with different vector/insert ratios, 
usually 1:1 and 1:5. Reaction was supplemented with T4 ligase buffer, filled up with ddH2O to 
10 µl and incubated for 30 min at 37 °C. The ligation reaction was subsequently used for 
transformation into chemically competent bacteria (3.2.1.1). 
3.2.1.7 Polymerase chain reaction (PCR) 
The polymerase chain reaction (PCR) was used for amplifying a particular DNA 
sequence. Hybridization of single stranded vector with primers will occur at a temperature 
dependent on the primer of choice (usually 45-60 °C). Heat-stable DNA polymerase elongates 
bound primers as an exact copy of the original template, doubling the target DNA sequence 
for every cycle resulting in an exponential amplification of the target sequence.  
For standard PCR, AccuPrimeTM Pfx was used. PCR reaction mixtures contained the 
equivalent of 20 ng template DNA, 5.0 µl 10x AccuPrimeTM Pfx reaction buffer, 1.5 µl of a 2 
mM dNTP mix, 1.5 µl of 10 mM forward primer, 1.5 µl of 10 mM reverse primer, 2.5 U 
AccuPrimeTM Pfx DNA polymerase and total volume was adjusted to 50 µl with ddH2O. In 
case of GC-rich templates, PCR reaction was supplemented with 5% DMSO. PCR was carried 
out as stated in Table 1. 
 
Table 1: Reaction cycle for AccuPrimeTM polymerase 
Cycle: Temperature Time #Cycles 
Initial Denaturation 97 °C 5 min 1 
Denaturation 97 °C 15 sec  
33 Annealing Tm -3°C to 5 C° 30 sec 
Elongation 68 °C 1 min/kb 
Final 68 °C 7 min 1 
Storing 4 °C ∞  
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3.2.1.8 Sequencing 
Sequencing of dsDNA was performed according to the dideoxy chain terminating 
method, as described before113. Sequencing PCRs were performed using the BigDye® 
terminator v3.1 cycle sequencing kit (Applied Biosystems). 
3.2.2 Mammalian Cell Culture 
3.2.2.1 Cell lines 
Cells used in this study are BJ hTERT SV40 HRas wt (BJ-ST), derived from BJ cells 
(human foreskin fibroblasts) by ectopic expression of telomerase catalytic subunit (hTERT), 
the simian virus 40 large-T oncoprotein and the HRas wt allele and the isogenic cell line, BJ 
hTERT SV40 HRas G12V (BJ-ELR), derived like the wt form but with the constitutively active 
form of HRas (HRas G12V)114. MCF7 (ECACC, Cat No. 86012803) cells were used for 
experiments when a low endogenous expression of EGFR was needed.  
3.2.2.2 Cultivation of immortalized mammalian cell lines 
Cells were routinely maintained in DMEM supplemented with 10 % fetal bovine 
serum (FBS), 2 mM L-Glutamin and 1 % non-essential amino acids (NEAA) in a humidified 
incubator at 37°C and 5 % CO2. Cells were passaged at a confluency of 80-90 % by aspiration 
of culture medium, 1 x washing with DPBS and addition of 1 ml Trypsin/EDTA, which was 
incubated on cells for 3 min at 37°C. Enzymatic reaction was stopped by addition of 10 ml 
fresh CGM. Cells were gently triturated and cell number was determined with a Vi-CELL XR 
cell viability analyzer. The required cell number was replated into fresh flasks or other cell 
culture dishes for desired experiments.  
3.2.2.3 Cryo-preservation of mammalian cell lines 
For long-term storage of cell lines cryo-stocks were prepared in cryo-medium (CGM + 
10 % DMSO) and kept in liquid nitrogen at –196 °C. DMSO serves as cryo-preservative 
preventing intracellular ice formation and thus decreased cell viability after thawing. 
For cryo-stock preparation cells were collected from T75 flasks as described above and 
diluted in cryo-media at a concentration of 3 x 106 cells/ml. Afterwards, 0.5 ml of the cell 
suspension were applied into pre-cooled cryo vials and transferred to a NALGENE® Cryo 1 °C 
freezing box filled with isopropanol, which allows a controlled freezing rate of 1 °C/min. Cells 
were kept at -80 °C overnight and on the next day cryo-stocks were transferred to a liquid 
nitrogen freezer for long term storage.  
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To thaw cells, cryo vials were placed into a 37 °C water bath and thawed cell 
suspension was diluted with minimum 10 ml of prewarmed CGM and transferred to a fresh 
T75 flask.  After reattachment of cells, medium was exchanged with fresh CGM to remove 
remaining DMSO.  
3.2.2.4 Transient transfection with Plasmid DNA 
Cell were transiently transfected with plasmid DNA with FuGENE 6 HD Transfection 
Reagent or Lipofectamine 2000 Transfection reagent according to manufacturer’s 
instructions. Both transfection procedures are based on liposome transfection. Positively 
charged lipids enclose the negatively charged DNA forming so-called liposomes, which can 
easily fuse with the cellular plasma membrane.  
For Transfection with FuGENE 6 HD Transfection Reagent cells were grown in the 
appropriate culture dish for 24 hrs to reach a confluency of 60-70 %. For Transfection with 
Lipofectamine 2000 Transfection Reagent cells were grown to a confluency of 80-90 % due to 
its higher cell toxicity. The transfection was performed with a DNA:transfection reagent ratio 
of 1:3. DNA and transfection reagent were diluted in serum-free medium according to Table 
2. Cells were incubated with the reaction mixture for 16-24 hrs at 37 °C in a humidified 
incubator with 5 % CO2 until required experiment was performed. 
 
Table 2: Transfection protocol for FuGENE and Lipofectamine 
Culture dish Surface area No. Cells Fugene 6 DNA Medium 
48-well 
8-well Labtek 
1 cm2 
0.8 cm2 
1.2-3.6 x 104 0.3 µl 0.10 µg 25 µl 
24-well 
4-well Labtek 
2 cm2 
1.8 cm2 
2.5-7.5 x 104 0.6 µl 0.20 µg 25 µl 
12-well 
2-well Labtek 
4 cm2 
 
0.5-1.5 x 105 1.5 µl 0.50 µg 50 µl 
 
Culture dish Surface area No. Cells Lipofectamine DNA Medium 
6-well 
35 mm dishes 
10 cm2 
9.6 cm2 
0.25-1 x 106 10 µl 4.0 µg 2 x 250  µl 
60-mm 20 cm2 0.5 - 2 x 106 20 µl 8.0 µg 2 x 500 µl 
10-cm 60 cm2 1.5 –6 x 106 60 µl 24 µg 2 x 1.5 ml 
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3.2.2.5 Real time cell analysis 
The xCELLigence real-time cell analysis (RTCA) is an assay based on dynamically 
measuring the impedance-based cell index (CI), a dimensionless unit representing cell 
attachment and thereby reflecting cell growth over time. Cells are grown on specific 16-well E-
plates with gold electrodes at the dish bottom to evaluate the ionic environment at the 
electrode/solution interface. The Dual Plate xCELLigence instrument correlates this 
information to the cell number over time.  
For the performed RTCA assays 7.5 x 103 cells were seeded per well and cell growth 
was monitored in total for 72 hrs. Before the cells were added to the dishes 100 µl CGM was 
used to blank the instrument. Afterwards the cells were added in another 100 µl CGM 
resulting in a final volume of 200 µl per well. The plates were then placed into the RTCA 
instrument kept in a humidified incubator at 37 °C and 5% CO2. The CI was monitored every 
15 min for 24 hours. Afterwards, the desired treatment was performed by addition of 20 µl 
medium with the indicated inhibitor or ctrl solution. Measurements were continued for 
another 24-48 hrs. For reliable results, each condition was performed as duplicates.  
3.2.2.6 Stimulation and Treatment of live cells 
Before stimulation with GF or treatment with H2O2, cells were starved overnight in 
starvation medium. Indicated concentration of either ligand or H2O2 were diluted in 
starvation medium and added to cells. Incubation was carried out for the indicated time in a 
humidified incubator at 37 °C and 5% CO2. If cells were treated with dimedone, DYn-2, DCP-
Rho1 or DCP-Bio1 treatment was performed in CGM without FCS. All probes were incubated 
at an endconcentration of 5 mM and for 10 min in a humidified incubator at 37 °C and 5% 
CO2, if not indicated otherwise. 
3.2.2.7 Loading cells with PF6-AM 
The intracellular H2O2 levels were detected with the dye PF6-AM (friendly provided by 
Chang lab, Departments of Chemistry and Molecular and Cell Biology, University of 
California, Berkeley, California)115. Cells were seeded on 4-well Lab-TekTM dishes and grown 
for two days. Cells were loaded with either 1 µM (BJ cells) or 5 µM (MCF7 cells) PF6-AM in 
PBS supplemented with Ca++/Mg++ for 20 min at 37 °C. The cells were then washed twice with 
fresh DMEM and imaged in phenol red free DMEM supplemented with 25 mM HEPES. For 
inhibitor experiments 10 µM DPI or equal amount of DMSO was incubated 10 min before 
PF6-AM was added and together with the dye for 20 min. PalmB or the equal amount of 
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DMSO was incubated at a concentration of 50 µM overnight. When stimulated with EGF, 
320 ng/ml EGF-Alexa647 was incubated simultaneously with PF6-AM. 
 
3.2.3 Biochemistry 
3.2.3.1 Preparation of whole cell lysates 
Whole cell lysates were prepared from mammalian cells grown in 35-mm or 60-mm 
tissue culture dishes. Before cell lysis, culture medium was aspirated and cells were washed 
once with ice-cold PBS. For cell lysis, 70 µl ice-cold lysis buffer supplemented with protease 
and phosphatase inhibitor cocktail tablet was added and incubated for 10 min on ice. Cells 
were scratched of the dish and transferred to a cold reaction tube. Lysates were cleared by 
centrifugation for 15 min at 15000 x g, at 4°C. Supernatant was transferred to a fresh 
precooled tube and pellet was discarded. Same steps were performed for cells treated with 
dimedone except that PBS was supplemented with 50 mM NEM and for lysis, and dimedone 
lysis buffer was supplemented only with protease inhibitor cocktail tablet.  
 
3.2.3.2 Determination of Protein Concentration with Bradford Assay 
The Bradford assay is a colorimetric protein assay used to determine the protein 
concentration of proteins in solution. It is based on the absorbance shift of the dye Coomassie 
brilliant blue G-250 from 465 nm to 595 nm when bound to hydrophobic amino acids. 
Therefore, the absorbance measurement at 595 nm is proportional to the protein 
concentration in the investigated solution. 
The protein concentration of all cell lysates was determined with the Bradford assay 
according to the manufacturer’s protocol. Protein standard was prepared by a serial dilution 
of a 1 mg/ml BSA stock solution obtaining concentrations ranging from 1-16 µg/ml in a total 
volume of 500 µl ddH2O. Accordingly, 1 µl of each sample of interest was also diluted in 500 
µl ddH2O in separate plastic cuvettes. For calibrating the spectrophotometer, 1 µl lysis buffer 
was diluted in 500 µl ddH2O and used as a blank sample. Finally, to each cuvette 500 µl 
Bradford reagent was added to receive a total volume of 1 ml. All samples were mixed and 
absorption was measured at 595 nm. Protein concentration of all lysates was determined by 
plotting the measured absorption values against the standard curve obtained by the prepared 
BSA standard. 
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3.2.3.3 Sample preparation for SDS-PAGE 
Protein concentration of whole cell lysates was adjusted to 20 µg per sample and 5x 
SDS loading buffer was added. For denaturation samples were boiled for 5 min at 95°C 
followed by centrifugation at max speed for 1min. For dimedone samples 4X XT Sample 
buffer supplemented with XT Reducing Agent was used and for 10 min at 70°C. 
 
3.2.3.4 Denaturating SDS-Polyacrylamid Gel Electrophoresis (SDS-PAGE) 
Denaturating SDS-Polyacrylamide Gel Electrophoresis (Sodium-dodecylsulfate-
polyacrylamid-gelelectrophoresis) is used to separate proteins according to their size and 
charge. The anionic detergent SDS prevents the formation of secondary and tertiary structures 
of polypeptide chains once denatured in the presence of a reducing agent. Additionally, the 
binding of SDS leads to an equalized distribution of charge per size of proteins, ensuring an 
evenly migration through a polyacrylamide matrix of proteins when an electric field is 
applied. Depending on the pore size of the gel, smaller polypeptide chains can migrate faster 
than bigger polypeptides and a separation is possible.  
All SDS-PAGEs were prepared in 1.5 mm thick empty gel cassettes compatible with 
the XCell SureLockTM Mini-Cell system.  Depending on the sample volume and number of 
samples either 10-, 12- or 15-well combs were used.  First the separating gel was poured in the 
cassette and after polymerization the stacking gel was added. The acrylamide concentration of 
the separating gel was adjusted to the molecular weight of the protein of interest and prepared 
according to the following recipe: 
 
Table 3: Recipe for SDS-PAGE (volumes indicated in ml) 
 Separating gel 8 % Separating gel 12 % Stacking gel 
ddH2O 7.0 5.0 4.1 
30 % Acrylamide mix 4.0 6.0 1.0 
1.5 M Tris (pH 8.8) 3.8 3.8 - 
1.0 M Tris (pH 6.8) - - 0.75 
10 % SDS 0.15 0.15 0.06 
10 % APS 0.15 0.15 0.06 
TEMED 0.009 0.009 0.006 
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For electrophoresis, the gels were locked into a XCell SureLockTM Mini-Cell gel 
chamber that was filled with 1x Running Buffer. The comb was carefully removed, each 
sample pocket was washed with 1x running buffer and loaded with the protein samples. For 
size determination 2 µl of Odyssey Two-Color Protein Molecular Weight Marker was applied 
to the first pocket. Electrophoresis was performed with constant voltage of 80 V till samples 
entered the separating gel and the voltage was increased to 130 V for approximately 90 min. 
3.2.3.5 Western Blot 
Western blot is a technique to detect specific proteins, which were electrophoretically 
separated and transferred to a nitrocellulose or PVDF membrane. Membranes can be stained 
with respective antibodies binding to the protein of interest.  
All Western Blots were performed with the XCell IITM Blot Module according to 
manufacturer’s instructions. To transfer the separated proteins from the polyacrylamide gel to 
the PVDF membrane, the separation gel was placed under a methanol-activated membrane. 
One Whatman filter paper and two sponges, equilibrated in ice-cold transfer buffer, were 
placed both under and above the blotting sandwich, respectively. The blotting module was 
placed in an XCell SureLock Mini-Cell, filled up with ice-cold transfer buffer and transfer was 
carried out with constant voltage of 40 V for 70 min.  
After the transfer, PVDF membranes were incubated with gentle shaking for 1 hour at 
RT with Li-Cor Odyssey Blocking Buffer in a Li-Cor incubation box. For labeling of the 
proteins of interest, the membranes were incubated on a shaker at 4 °C overnight with the 
respective primary antibodies diluted in Li-Cor Odyssey Blocking Buffer. On the next day, 
membranes were incubated with IRDye secondary antibodies diluted in Odyssey Blocking 
Buffer for 40 min at RT. IRDye labeled Straptavidin was used for DCP-Bio1 detection. After 
incubation of both primary and secondary antibodies, the membranes were washed 3 x with 
TBTS/T for 10 min at RT. Finally, membranes were scanned with the Li-Cor Odyssey imaging 
system. 
3.2.3.6 Immunoprecipitation 
Cell lysis and determination of protein concentration for Immunoprecipitation (IP) 
were carried out as described in 3.2.3.1 and 3.2.3.2. For isolating the protein of interest, the 
respective antibody was immobilized on Protein-G-Sepharose beads (PG-beads) and the 
whole protein lysate was incubated with the antibody-bound beads. All mentioned 
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centrifugation steps were carried out at a speed of 850 x g to avoid protein damage caused by 
added beads. 
Agarose PG beads were washed 4 x with ice cold PBS by repeated steps of 
centrifugation for 2 min at 4 °C, aspiration of the supernatant and addition of fresh PBS. After 
the last centrifugation, beads were diluted in the same amount of PBS to obtain a 50 % PG-
bead solution. To get rid of proteins binding unspecific to PG-beads, 500 µl protein lysate 
(0.2-1 mg protein) was precleared with 20 µl beads for 1 hr at 4 °C on a wheel-over-wheel-
shaker. After centrifugation for 2 min at 4 °C, supernatant was collected in a fresh tube and 
the respective antibody was added and incubated overnight at 4 °C on a wheel-over-wheel-
shaker. On the next day, 30 µl PG-beads were added to each sample and rotated for yet 
another 2 hr. Samples were washed 4 x with ice cold lysis buffer. After the last washing step, 
proteins bound to beads were eluted by adding 20 µl Laemmli buffer (1X), shortly vortexed 
and boiled for 5 min at 95 °C. Afterwards, samples were centrifuged for 1 min at max speed 
and loaded on SDS-gels. Following steps were carried out as described in 3.2.3.4 and 3.2.3.5.  
3.2.3.7 In vitro oxidation of PTP1Bc 
Recombinant PTP1Bc (in 25 mM Tris, 150 mM NaCl, 5 % Glycerol) was loaded on 
Microcon 3 kD YM-3 membrane and centrifuged at 4 °C, 13000 x g for roughly 60 min till 
most of the buffer was separated from the protein. For recovery, sample reservoir was placed 
upside down in a fresh tube and centrifuged for 3 min at 1000 x g, 4 °C. Protein concentration 
was determined via Bradford assay (3.2.3.2) and concentration was adjusted with degassed 
PBS to 4 mg/ml (108 mM). PTP1Bc was fully reduced by treatment with 1 mM DTT for 20 
min at 0 °C. DTT was removed by using again an Microcon 3 kD YM-3 membrane and 
protein concentration was determined via Bradford. For each sample 10 mM protein was 
either treated with 5 mM dimedone or the equivalent amount of DMSO and different 
concentrations of H2O2 for 30 min at RT while gently shaking. Reaction was stopped by 
addition of 20 mM NEM and 4X reducing XT sample buffer. Samples were denatured at 70 °C 
for 5 min. Detection was carried out as described in 3.2.3.5. 
3.2.3.8 Denaturating Bis-Tris-Polyacrylamid Gel Electrophoresis for dimedone detection 
The biochemical detection of oxidized proteins derivatized with dimedone was 
performed similarly to normal gel electrophoresis (3.2.3.4). For electrophoresis, precast 
NuPAGE 4-12 % Bis-Tris-Gels together with NuPAGE MOPS SDS Running buffer for whole 
protein lysates or NuPAGE MES SDS Running buffer for PTP1Bc in vitro samples. Running 
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buffer in the inner chamber was supplemented with NuPAGE Antioxidant. After loading of 
samples, electrophoresis was performed at constant voltage of 200 V for 45-50 min. 
Afterwards, western blot was performed as described in 3.2.3.5. 
3.2.3.9 Labeling of DYn-2 via cupper-catalyzed click chemistry 
Cell were washed once with PBS + 20 mM NEM and subsequently fixed with Roti®-
Histofix 4 % supplemented also with 20 mM NEM for 10 min at RT. Fixative was removed by 
washing cells 3 x for 5 min with TBS and cells were permeabilized with PBS + 0.1 % Triton X-
100 for 5 min at RT. Afterwards, cells were washed 3 x for 5 min with PBS and unspecific 
binding was prevented by incubation of cells with Image-iT FX Signal Enhancer for 60 min at 
RT. For the click-chemistry reaction the following mixture was prepared: 
 
Table 4: Click-Chemistry reaction mix 
 Stock concentration Final concentration 
Alexa594-Azide 5 mM in DMSO 100 µM 
CuSO4 50 mM in H2O 1 mM 
TCEP 50 mM in H2O 1 mM 
TBTA 10 mM in DMSO 100 µM 
 
The components were added in the above-mentioned order and after every step the 
reaction was shortly vortexed. Before addition of TBTA the reaction was incubated for 2 min 
at RT. After addition of TBTA, PBS was added to obtain the final concentration stated in 
Table 4. Afterwards, mixture was diluted again 3x with PBS and 145 µl were added on each 
well and incubated for 1 hr at RT in the dark. To stop the reaction, click-chemistry mixture 
was removed and cells were washed 2 x 5min with PBS + 1% Tween-20 and 0.5 mM EDTA 
and 2 x 5 min with PBS. Finally, cells were directly imaged in PBS. 
3.2.3.10 Immunocytochemistry 
Cells were treated as indicated, once washed with PBS and fixed with Roti®-Histofix 4 
% for 10 min at RT. Fixative was removed by washing 3 x with TBS for 5 min at RT. 
Permeabilization was carried out with TBS supplemented with 0.1% TritonX-100 for 5 min at 
RT, followed by three wash steps with TBS for 5 min at RT. To prevent unspecific antibody-
binding, cells were blocked with Li-COR Odysseys blocking buffer for min 30 min at RT and 
then incubated with primary antibodies for 60 min at RT. Cells were washed 3 x with TBS and 
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secondary antibodies were incubated for 30 min at RT. Excess antibody was removed by three 
further washing steps with TBS. When needed, cell nuclei were stained with Hoechst-reagent 
diluted in TBS (1:10000) for 15 min at RT and then washed once with PBS. Finally, cells were 
imaged in PBS with the appropriate microscope.  
3.2.3.11 PhosTag preparation and labeling of fixed cells 
Streptavidin (STV) was dissolved in PBS and washed twice with PBS using an Amicon 
30 kDa cut-off. Absorption was measured at 280 nm and concentration was adjusted to 100 
µM (calculated according to Lambert-Beer; extinction coefficient: 165000 M-1cm-1). Bicine 
(pH 9.3) was added to the STV solution resulting in 0.1 M. Monofunctional Cy3.5 was 
dissolved in 10 µl DMF and dye concentration was determined by measuring the absorption 
at 581 nm. For labeling, a 10-fold excess of dye was added to the STV solution and incubated 
for 45 min at RT and afterwards purified twice by gel exclusion chromatography using protein 
desalting spin columns. Phos-Tag-Biotin was added in a 200-fold excess to STV-Cy3.5 in 
TBS/T supplemented with 0.4 mM Zn(NO3)2 and incubated for 30 min at RT. Mixture was 
cleared using gel exclusion chromatography with Zebra Spin Desalting Columns 40 kDa cut-
off. Cells were plated and transfected as described earlier (3.2.2.4). After overnight starvation 
with medium containing 0.5 % FCS, cells were treated as described, once washed with PBS 
and fixed with Roti-Histofix 4 % for 10 min at RT. To remove PFA, cells were washed 3 times 
with TBS and afterwards permeabilized with TBS containing 0.1 % Triton X-100 for 5 min at 
RT. Cells were washed 3 x with TBS/T and 170 nM Phos-Tag-Cy3.5 complex in TBS/T was 
incubated for 1 hr at RT. Finally, cells were washed once with TBS/T and imaged in PBS.  
3.2.3.12 Staining of DCP-Bio1 with STV-Cy3.5 
STV-Cy3.5 was prepared as described in 3.2.3.11. After incubation of DCP-Bio1, cells 
were fixed with Roti®-Histofix 4 % for 10 min at RT. Permeabilization was carried out with 
TBS supplemented with 0.1% TritonX-100 for 5 min at RT, followed by three wash steps with 
TBS for 5 min at RT. To prevent unspecific staining, cells were blocked with Image-iT FX 
Signal Enhancer for min 60 min at RT. STV-Cy3.5 was incubated overnight at a concentration 
of 300 nM at 4 °C and subsequently removed by washing 3 x 5 min with PBS. Finally, cells 
were directly imaged in PBS. 
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3.2.4 Microscopy 
3.2.4.1 Confocal laser-scanning microscopy (LSM) 
Olympus FV1000 
Confocal images at the Olympus FV1000 equipped with a 60x/1.35 NA oil objective and a 
temperature controlled incubation chamber were acquired in sequential mode frame by 
frame. mTagBFP/DAPI were excited with a 405 nm diode laser, mCitrine/Alexa488 with a 488 
nm Argon laser, mCherry/Alexa594 with a 561 nm DPSS laser and Alexa647 with a 633 nm 
Helium-Neon laser using the DM405/488/561/633 dichroic mirror. Detection of blue 
fluorescence emission was restricted to a bandwidth of 425-478 nm and was collected using a 
bandwidth of and through a SDM490 emission beam splitter. Yellow fluorescence was 
detected between 498-551 nm using the SDM560 beam splitter. Red fluorescence was detected 
in the bandwidth of 575-623/675 nm depending on the presence of a far red fluorophore and 
separated from the far red emission using a SDM640 beam splitter. All images were 2x 
averaged and acquired with a pinhole size of 250 µm or 400 µm. Live cells were imaged in 
imaging medium, whereas fixed cells were imaged in PBS. All images were acquired at 37 °C 
and 0 % CO2. 
LeicaSP8 
The LeicaSP8 was equipped with a HC PL APO CS2 60x/1.4 NA oil objective and an 
environmental-controlled chamber at 37°C. mCitrine and mCherry were excited at 488 nm 
and 561 nm, respectively using a 470-670 nm white light laser. Detection of fluorescence 
emission was restricted with an Acousto-Optical Beam Splitter (AOBS) to the following 
bandwidth – mCitrine (498-551 nm) and mCherry (575-675 nm). Images were obtained in 
sequential mode and the pinhole was set to 3 airy units. Live cells were imaged in imaging 
media at 37 °C. 
 
3.2.4.2 Fluorescence lifetime imaging microscopy (FLIM) 
Fluorescence lifetime imaging microscopy (FLIM) is a method to quantitatively 
analyze Förster resonance energy transfer (FRET) in a biochemical context116. FRET is the 
non-radiative transfer of energy by dipole-dipole coupling between two fluorophores that are 
within a few nanometers of each other and can only occur under the condition that the 
emission spectrum of the donor fluorophore sufficiently overlaps with the excitation 
spectrum of the acceptor117.   
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Confocal FLIM experiments were performed using a time-correlated single-photon 
counting module on an Olympus FV1000 confocal microscope. The pulsed laser was 
controlled with the Sepia II software at a pulse repetition rate of 40 MHz. In each sample 
mCitrine served as donor molecule and was excited with a 507 nm diode laser. Fluorescence 
emission was spectrally filtered using a bandpass emission filter (537/25). Photons were 
detected using a single-photon counting avalanche photodiode and timed using a single-
photon counting module using the SymPhoTime software V5.13. Images were collected after 
an integration time of ~ 3 min. 
3.2.5 Image analysis 
3.2.5.1 FLIM analysis with global analysis 
FLIM analysis using global analysis118 implemented into MatLab based on frequency 
domain analysis of TCSPC data119. All data from the same experiment using the same donor 
molecule were pooled together and jointly analyzed. For each pixel, the single photon arrival 
times of the TCSPC measurement were used to calculate the complex Fourier coefficients of 
the first harmonic. In a second step, the Fourier coefficients were corrected by the Fourier 
coefficient of a calculated reference119. The corrected Fourier coefficients are then plotted into 
a phasor plot, so that the Fourier coefficients from each pixel of the image are represented by 
one point in the phasor plot. By fitting a straight line through all points in the phasor plot, the 
“global lifetimes” τD and τDA are determined at the intersections with the half-circle. The half-
circle represents all possible values of mono-exponential lifetimes, wheras all points within the 
half-circle represent all possible mixtures od two mono-exponential species. τDA is the donor 
fluorescence lifetime in presence of the acceptor and τD the donor-only lifetime. Finally, the 
projection of each point in the phasor plot into the fitted segment between τD and τDA can be 
used to calculate the relative fraction of donor-only and donor-acceptor pairs (α) in each 
pixel. 
3.2.5.2 Single cell segmentation 
Cells were segmented in CellProfiler120 using the image of the nuclear stain (PhosTag) 
and EGFR-mCitrine. All images were corrected for background and bleed through, and mean 
values per cell (excluding the nuclear region) from all channels were obtained.  
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3.2.5.3 HyPer image analysis 
Images were processed with Fiji ImageJ software. First, images were converted into 32-
bot and background corrected. Either images excited with 405 nm or 561 nm were 
thresholded to set background pixels to ‘Not a number’ (NaN). Afterwards the ratio between 
488/405 or 488/561 was calculated and mean values for each cell were measured. Values for 
each cell were normalized to images taken before stimulation to obtain the fold increase upon 
treatment. 
3.2.6 Statistical Analysis 
Results are expressed as the mean ± SEM, unless otherwise stated. Statistical 
significance of ungrouped data was estimated by Student’s t-test. Statistical significance of 
grouped data was estimated by two-way ANOVA. For two-way ANOVA a Bonferroni 
correction was performed and adjusted p-values were calculated and indicated in the 
corresponding figures.  
   52 
4 RESULTS 
4.1 Intracellular H2O2 production 
4.1.1 Ras- and EGFR-dependent regulation of intracellular H2O2 levels 
Gain of function mutations such as the frequently found G12V substitution in the Ras 
oncogene, are common drivers of tumor formation and progression. Malignant 
transformation is often associated with higher ROS levels either caused by enhanced cellular 
stress, higher cellular metabolism or direct activation of ROS producing enzymes by the 
oncogene. In this study, we used immortalized normal human BJ fibroblasts (BJ-ST; here wt 
cells) and compared them with an isogenic cell line stably infected with the oncogenic form of 
HRas (HRas G12V; BJ-ELR cells; here G12V cells)114. To test whether HRas G12V leads to 
higher H2O2 levels, the cell permeable dye PF6-AM was used, which increases in fluorescence 
when H2O2 is present due to a boronate chemical switch115.  Indeed, we could show that the 
basal intracellular H2O2 level was nearly twofold higher in G12V cells as compared to wt cells 
(Figure 4.1 A).  
To identify if the measured H2O2 production was caused by an activation of NOX 
proteins, both cell lines were treated with the common NOX inhibitor DPI121, and H2O2 levels 
were monitored again with PF6-AM. Incubation with DPI led to a dramatic decrease in H2O2 
levels in both cell types indicating active NOX enzymes as the main source of intracellular 
H2O2 production in resting BJ cells (Figure 4.1 B).  To uncouple NOX activation and 
subsequent H2O2 production from active Ras signaling, we blocked depalmitoylation of 
palmitoylated Ras by inhibiting the acyl protein thioesterease 1 (APT1) with palmostatin B 
(PalmB). Inhibition of APT1 by PalmB disturbs the steady-state localization of Ras by 
randomizing its localization to all membranes and thus leading to a perturbation of Ras 
signaling activity122. When BJ cells were pre-incubated with PalmB and H2O2 levels were 
detected with PF6-AM, a significant decrease in fluorescence was detected for both cell types 
implicating low H2O2 levels (Figure 4.1 C). This indicates that NOX activation and thus H2O2 
production is dependent on active Ras signaling, in untransformed and oncogenic cells. 
However, treatment with PalmB led to a more significant decrease of H2O2 levels in G12V 
cells showing that Ras transformation has a high impact on intracellular ROS production.  
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Figure 4.1: HRas G12V increases H2O2 production by activation of NOX enzymes 
(A) Representative fluorescence images of unstimulated wt and G12V cells incubated with the H2O2 sensitive 
probe PF6-AM. Graph shows average ± SEM of mean fluorescence intensity of three independent experiments 
each with 5-7 fields of view (confluent layer of cells). P values were calculated by Student’s t test. Scale bar: 10 µm 
(B) Representative fluorescence images of unstimulated wt and G12V cells pre-incubated either with 10 µM DPI 
or DMSO and then loaded with PF6-AM. Plot on the right shows average ± SEM of mean fluorescence intensity 
of three independent experiments each with 5-7 fields of view (confluent layer of cells). P values were calculated 
by two-way ANOVA. Scale bar: 10 µm (C) Representative fluorescence images of cells treated either with 50 µM 
PalmB or DMSO overnight and then loaded with PF6-AM. Plot on the right shows average ± SEM of mean 
fluorescence intensity of two independent experiments each with 5-7 fields of view (confluent layer of cells). P 
values were calculated by two-way ANOVA. Scale bar: 10 µm 
   54 
To check if the production of H2O2 is mediating normal cell growth, we performed 
real-time cell analyzer (RTCA) assays of wt and G12V cells with increasing concentrations of 
DPI. Cells were first grown in complete growth medium without the inhibitor, which was 
added after 24 hrs when cells were fully attached. In wt cells, addition of 3 and 5 µM did not 
have any significant effect on cell growth and first addition of 10 µM DPI led to increased 
apoptosis indicated by a decreasing cell index (Figure 4.2 A). In contrast, G12V cells already 
showed impaired cell growth after treatment with 3 µM DPI getting more pronounced with 
higher DPI concentrations (Figure 4.2 A). By comparing the relative growth rates, we could 
show that the growth of G12V cells is highly dependent on intracellular H2O2 production 
whereas wt cells continued to proliferate even in the presence of DPI (Figure 4.2 B).  
 
 
Figure 4.2: Dependency of cell growth on NOX activity 
(A) Growth curves of wt (left) and G12V cells (right) recorded by RTCA measurements. Both cell types were 
treated with indicated concentrations of DPI or DMSO. Curves were normalized to the cell index value before 
inhibitor was added. Lines under curves represent the values used for calculating the relative growth rate (B) 
Relative growth rates of three independent experiments showing mean values ± SEM obtained by calculating the 
quotient before and after inhibitor addition. P values were calculated by Student’s t-test. 
 
Ras usually acts downstream of RTKs linking the production of H2O2 to active growth 
factor signaling. One of the most studied RTKs is EGFR, a receptor that has been shown to 
evoke H2O2 production and is like Ras often hyperactivated in human cancers26,123. To study if 
not only Ras but also the upstream EGFR can enhance the intracellular H2O2 production, we 
overexpressed EGFR-mCherry in MCF7 cells, a cell line with a low endogenous EGFR 
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expression level124. When incubated with PF6-AM, cells with higher EGFR-mCherry 
expression showed a tendency for higher intracellular H2O2 concentrations (Figure 4.3 A). 
This correlation became even more distinct when cells were stimulated with EGF provoking 
full receptor activation (Figure 4.3 B). In contrast, pre-incubation with DPI led to an overall 
decrease in H2O2 levels, showing that activation of NOX enzymes is also necessary for EGFR-
dependent H2O2 production (Figure 4.3 C, D).  
 
 
Figure 4.3: H2O2 production in dependence to EGFR expression in MCF7 cells  
(A) Dependence of H2O2 levels (F of PF6-AM) on EGFR-mCherry expression level (F of EGFR) obtained for 
unstimulated MCF7 cells. Black dots represent fluorescence intensities (F) for EGFR-mCherry and PF6-AM per 
cell and red line represents binned average ± SEM. (B) Dependence of H2O2 levels as measured by PF6-AM 
fluorescence on EGFR-mCherry expression level obtained for MCF7 cells stimulated with 100 ng/ml EGF. (C) 
Dependence of H2O2 levels as measured by PF6-AM fluorescence on EGFR-mCherry expression level obtained 
for MCF7 cells pre-treated with 10 µM DPI. Black dots represent fluorescence intensities for EGFR-mCherry and 
PF6-AM per cell and red line represents binned average ± SEM. (D) Binned averages for all three conditions 
showed in (A), (B) and (C). 
4.1.2 Spatial-temporal dynamics of H2O2 production upon EGF stimulation 
Sine we could show that H2O2 production is dependent on both active Ras signaling 
and EGFR activation, we continued with detecting the temporal dynamics of H2O2 production 
upon EGF stimulation. Therefore, we used the genetically encoded sensor HyPer3125 in BJ cells 
with endogenous EGFR levels and in MCF7 cells, where we ectopically expressed the receptor. 
HyPer3 consists of a circularly permutated YFP (cpYFP) flanked by the OxyR domains from 
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E.coli. Upon exposure to H2O2 a disulfide is formed between Cys199 and Cys208 leading to an 
increased fluorescence emission (500-530 nm) when excited at 488 nm and a decreased 
fluorescence emission when excited at 405 nm, enabling a ratiometric readout, which is 
insensitive to random fluctuations caused, for instance, by cell shape changes or focus drift126. 
Additionally, HyPer can be reduced by the cellular antioxidant system making it suitable for 
the detection of dynamic changes of intracellular H2O2 concentrations.   
First, we used the originally published cytoplasmic form of HyPer3 (cHyPer3) 
expressed in BJ wt and G12V cells. To test the dynamic range and reversibility of the sensor, a 
high concentration of exogenous H2O2 was added to both cell types, followed by addition of 
the reducing agent DTT. As expected, an increased fluorescence was detectable when excited 
at 488 nm and a corresponding decrease was detectable when excited at 405 nm upon 
addition of H2O2 (Figure 4.4 A).  In contrast, addition of DTT induced the opposite effect in 
both cell types, verifying the reversibility and ratiometric readout of cHyPer3.  Interestingly, 
fold increase upon H2O2 of cHyPer3 was higher in wt cells compared to G12V cells and 
accordingly, fold decrease was upon DTT administration faster in G12V cells (Figure 4.4 B).  
 
 
Figure 4.4: Oxidation/reduction cycle of cHyPer3 
(A) First row shows pseudocolored images of the 488/405 fluorescence ratio of cHyPer3 expressed in BJ cells 
treated as indicated. Middle row shows fluorescence images of cHyPer3 excited with the 488 nm laser line (F488) 
and lower row shows excitation at 405 nm (F405). Scale bar: 20 µm (B) Plot shows average ± SEM of 488/405 
ratio upon treatment with H2O2 or DTT as indicated for 6-8 cells per cell type. 
 
In addition to the cytoplasmic HyPer3 version, a membrane anchored (HyPer3-TK) 
and an ER-anchored (HyPer3-ER) version were tested to map the spatial-temporal 
production of H2O2 upon EGF stimulation. HyPer3-TK consists of the truncated C-terminal 
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HVR of KRas fused to cHyPer3 and HyPer3-ER is a fusion of the ER-anchor from PTP1B and 
cHyPer3. When expressed in BJ cells both constructs showed a correct localization, a clear 
fluorescence at the PM for HyPer3-TK and ER staining HyPer3-ER (Figure 4.5). To test if 
trapping the sensor to an intracellular compartment hinders its reversible ratiometric readout, 
the same controls were performed as for cHyPer3 (Figure 4.5). HyPer3-TK shows a slightly 
lower fold increase of the F488/F405 ratio compared to the cHyPer3 construct upon treatment 
with the same concentration of H2O2. Interestingly, addition of 2 mM DTT was not sufficient 
to reduce HyPer3-TK and an addition of 4 mM DTT was required to significantly decrease 
the F488/F405 ratio in both cell types (Figure 4.5 A). This could indicate that the cytoplasm 
has a higher reduction potential than the PM. Similar to cHyPer3, HyPer3-TK shows less 
oxidation and a faster reduction when expressed in G12V cells.  
The oxidation dynamics of HyPer3-ER were similar in both cell types upon addition of 
H2O2 (Figure 4.5 B). Reduction of the construct was not detectable upon treatment with 2 mM 
DTT as already observed for HyPer3-TK. Upon addition of 4 mM DTT a decrease in the 
F488/F405 ratio was detectable for both cell types, although wt cells showed a slower 
reduction than G12V cells.  
 
 
Figure 4.5: Oxidation/reduction cycle of HyPer3-TK and HyPer3-ER 
(A) Left panel shows pseudocolored images of the 488/405 fluorescence ratio of cells treated as indicated and 
expressing HyPer3-TK. Plot on the right panel shows average ± SEM of 488/405 ratio per time point upon 
treatment with H2O2 or DTT as indicated for 6-8 cells per cell type. Scale bar: 20 µm (B) Left panel shows 
pseudocolored images of the 488/405 fluorescence ratio of cells treated as indicated and expressing HyPer3-ER. 
Plot on the right panel shows average ± SEM of 488/405 ratio per time point upon treatment with H2O2 or DTT 
as indicated for 6-8 cells per cell type. Scale bar: 20 µm 
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Further on, all three constructs were used to map compartment-specific H2O2 
production upon EGF-Alexa647 (320 ng/ml) stimulation in BJ cells. Only cHyPer3 showed an 
increase in the F488/F405 ratio in G12V cells (Figure 4.6 A) whereas all other constructs 
didn’t change upon EGF stimulation or even decreased (Figure 4.6 B, C). This indicates that 
H2O2 production upon EGF stimulation is only detectable in the cytoplasm of G12V cells 
when stimulated with EGF.  
 
Figure 4.6: H2O2 production in different cellular compartments upon EGF stimulation 
(A) Pseudocolored images on the left represent the 488/405 fluorescence ratio (upper row) of wt cells expressing 
cHyPer3 at different time points after stimulation with EGF-Alexa647 (lower row). Graph on the right shows 
temporal dynamics of H2O2 production upon EGF-Alexa647 stimulation in wt and G12V cells detected by 
488/405 fluorescence ratio of cHyPer3. Every time point represents average ± SEM of 488/405 fluorescence ratio 
of minimum 30 different cells. Arrow indicates addition of EGF-Alexa647 (320 ng/ml); images were taken every 
1 min. Scale bar: 20 µm (B) Pseudocolored images on the left represent the 488/405 fluorescence ratio (upper 
row) of wt cells expressing HyPer3-TK at different time points after stimulation with EGF-Alexa647 (lower row). 
Graph on the right shows temporal dynamics of H2O2 production upon EGF-Alexa647 stimulation in wt and 
G12V cells detected by 488/405 fluorescence ratio of HyPer3-TK. Every time point represents average ± SEM of 
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488/405 fluorescence ratio of minimum 30 different cells. Arrow indicates addition of EGF-Alexa647 (320 
ng/ml); images were taken every 1 min. Scale bar: 20 µm (C) Pseudocolored images on the left represent the 
488/405 fluorescence ratio (upper row) of wt cells expressing HyPer3-ER at different time points after 
stimulation with EGF-Alexa647 (lower row). Graph on the right shows temporal dynamics of H2O2 production 
upon EGF-Alexa647 stimulation in wt and G12V cells detected by 488/405 fluorescence ratio of HyPer3-ER. 
Every time point represents average ± SEM of 488/405 fluorescence ratio of minimum 30 different cells. Arrow 
indicates addition of EGF-Alexa647 (320 ng/ml); images were taken every 1 min. Scale bar: 20 µm 
It was surprising that all HyPer constructs when expressed in BJ cells just showed a 
minor or no increase upon EGF stimulation, whereas a clear increase in H2O2 levels was 
detectable in MCF7 cells when measured with PF6-AM (Figure 4.3). Therefore, we tried to 
optimize the detection of the HyPer construct since the direct ratiometric readout displays 
some drawbacks. For instance, the excitation at 405 nm is likely to bleach fluorophores or 
could induce to the production of ROS that oxidizes HyPer prior to EGF stimulation.  
As an alternative, we tested a two-fluorophore system consisting of cHyPer3 and co-
expression of mCherry as reference. In this case, HyPer was just excited with the 488 nm laser 
line and mCherry fluorescence intensity excited at 561 nm should correct for H2O2 
independent changes, which are for example caused by changes upon cell movement or focus 
drift. This system was first tested in EGFR-expressing MCF7 cells as in those cells a clear H2O2 
increase upon EGF stimulation was detectable with measured with PF6-AM (Figure 4.3). 
Labeled EGF (EGF-Alexa647) was used to visualize EGFR overexpression. Upon EGF 
stimulation the F488/F561 ratio increased fast and plateaued after 3 min reflecting production 
of H2O2 (Figure 4.7). For the control measurement, where just medium was added to the cells, 
no change was detectable indicating a specific increase of H2O2 upon EGF stimulation. In 
general, the two-fluorophore system is less noisy and more sensitive making it preferable for 
measuring the temporal dynamics of H2O2 production upon GF stimulation. 
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Figure 4.7: Detection of EGF induced H2O2 production in MCF7 cells with cHyper3-mCherry system 
Pseudocolored images of the normalized 488/561 fluorescence ratio (upper row) of MCF7 cells expressing 
cHyPer3 (second row) and mCherry (third row) at different time points after stimulation with EGF-Alexa647 
(320 ng/ml; lower row) Scale bar: 20 µm. Graph on the right shows temporal dynamics of H2O2 production upon 
EGF-Alexa647 stimulation (n = 11 cells) and for the ctrl case (n = 9 cells). Every time point represents average ± 
SEM of 488/561 fluorescence ratio normalized to the mean intensity of 5 images taken before EGF/medium 
addition as indicated by the arrow. 
 
The same method was used to measure H2O2 production in BJ cells upon EGF 
stimulation without overexpressing the receptor (Figure 4.8 A). Consistent with data from 
MCF7 cells, the F488/F561 ratio showed a significant increase after EGF addition in both cell 
types. However, G12V cells showed a higher increase than wt cells concordant with the 
previous obtained H2O2 measurements at basal level (Figure 4.6, Figure 4.8 B). Comparable to 
the results in MCF7 cells, H2O2 production plateaued around 5 min after stimulation and did 
not decrease further. Although reversibility was tested before (Figure 4.4), it is possible that 
the endogenous antioxidant system is not sufficient for reducing overexpressed HyPer3 once 
oxidized. These results proof that EGF stimulation leads to an increase in H2O2 levels and that 
the presence of constitutively active HRas even further increases the production. 
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Figure 4.8: Detection of EGF induced H2O2 production in BJ cells with cHyper3-mCherry system 
(A) Pseudocolored images of the 488/561 fluorescence ratio (upper row) of BJ G12V cells expressing cHyPer3 
(middle row) and mCherry (lower row) at different time points after stimulation with EGF (100 ng/ml). Scale 
bar: 20 µm. (B) Graph shows temporal dynamics of H2O2 production upon EGF stimulation for wt (n = 29) and 
G12V cells (n = 29). Every time point represents average ± SEM of 488/561 fluorescence ratio normalized to the 
image taken before stimulation. P values were obtained by Student’s t-test; significance as shown by (*) 
represents p < 0.05.  
 
4.1.3 Detection of NOX enzymes 
We could show that inhibition of NOX enzymes by DPI led to a decreased intracellular 
H2O2 production and that the presence of constitutively active HRas increases the intracellular 
H2O2 production. For a better understanding of the molecular mechanism of H2O2 production 
in BJ cells, we investigated two members of the NOX family. On the one hand we checked for 
NOX2 expression, which is GF-regulated and PM-located. On the other hand, we focused on 
NOX4, which is expressed on the ER and in contrary to NOX2 constitutively active3. First, we 
checked for total protein expression level of these proteins via western blot analysis of whole 
cell lysates of BJ cells (Figure 4.1 A, B). Although H2O2 production was higher in G12V cells, 
NOX2 and NOX4 levels are comparable in both cell types (Figure 4.9 A, B). Since NOX4 is 
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constitutively active a similar expression level in both cells indicates that this NOX enzyme is 
not responsible for higher H2O2 levels in G12V cells. Therefore, we continued with 
immunostainings of NOX2 revealing an accumulation of the protein at the PM in G12V, 
which even increases upon EGF stimulation (Figure 4.9 C). This distinct staining pattern was 
not detected in wt cells. This indicates that constitutively active HRas triggers NOX2 assembly 
and activation in resting cells leading to higher H2O2 levels in unstimulated and EGF 
stimulated cells. In addition, EGF stimulation in G12V cells can even increase NOX2 
activation leading to elevated H2O2 levels. 
 
 
Figure 4.9: Expression level and spatial distribution of NOX enzymes in BJ cells  
(A) Western blot of whole cell lysates detecting NOX2 levels in BJ wt and G12V cells in triplicates. Tubulin 
serves as loading control. (B) Western blot of whole cell lysates detecting NOX4 levels in BJ wt and G12V cells in 
triplicates. GAPDH serves as loading control. (C) Representative images of NOX2 immunostaining in untreated 
and EGF treated (50 ng/ml) BJ cells. Boxes indicate regions of interest that are blown up below the original image 
showing NOX2 staining in the periphery of the cell. Scale bar: 50 µm 
 
Taken together, we could show that EGF stimulation induces H2O2 production via 
activation of NOX enzymes and that constitutively active HRas leads to an increase of 
intracellular H2O2, at basal level and upon EGF stimulation.  
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4.2 Effect of H2O2 production on EGFR phosphorylation dynamics 
Inhibition of PTPs by EGF-induced H2O2 production together with the autocatalytic 
activation mechanism of EGFR exemplifies a double negative feedback ensuring robust 
threshold-activated receptor phosphorylation94. Thus, we hypothesized that increased H2O2 
levels as caused by gain of function mutations of oncogenes as shown here for HRas, can 
influence this delicate balance between RTK activation and PTP inhibition.  
4.2.1 Ligand dependent EGFR activation in BJ cells 
In the previous experiments, EGF stimulation has been shown to trigger H2O2 
production but receptor activation itself and how it could be affected by H2O2 was not 
considered. The classical EGFR activation scheme follows ligand binding, receptor 
dimerization, auto-phosphorylation in trans and recruitment of adaptor proteins resulting in 
signal transduction64. To examine, if higher H2O2 levels caused by HRas G12V promote EGFR 
activity, BJ cells were stimulated with 50 ng/ml EGF for different time points and receptor 
phosphorylation was analyzed from whole cell lysates via western blot. For both cell lines, 
EGFR phosphorylation, as probed with the generic phospho-tyrosine antibody PY72, peaked 
5 min after stimulation and declined to basal level within 60 min (Figure 4.10). The overall 
phosphorylation profile of EGFR is highly similar in both cell lines and apart of non-
significant differences at later time points, HRas G12V cells did not show an enhanced 
receptor activation. 
 
 
Figure 4.10: Temporal phosphorylation profile of EGFR upon EGF stimulation in BJ cells 
Left panel shows representative western blot images of phosphorylated EGFR at different time points upon EGF 
stimulation (50 ng/ml) in BJ wt and G12V cells. Plot on the right shows mean ratio ± SEM of phospho-tyrosine 
signal over total EGFR signal at indicated time points after EGF stimulation (n=2). 
 
Since population means as obtained by western blotting often miss out phenotypic 
differences among individual cells and do not provide any information about cell-to-cell 
variance or spatial regulation of protein activities, we analyzed EGFR phosphorylation in BJ 
   64 
cells via single live-cell imaging using FLIM. For detection of activated EGFR, EGFR-
mCitrine, serving as donor molecule, and PTB-mCherry, serving as acceptor molecule, were 
overexpressed in BJ cells. Binding of PTB to the phosphorylated receptor results in FRET 
between both fluorophores enabling the computation of the fraction of phosphorylated EGFR 
(α). Upon stimulation with EGF (100 ng/ml), α quickly increased in both cell types and stayed 
relatively stable over the measured time course (Figure 4.11). EGFR phosphorylation peaked 
at the PM forming a gradient, which declined towards the cell interior. PTB-mCherry was not 
imaged to prevent bleaching of the acceptor, which could result in an artificial increase in α. 
Imaging of several cells revealed that EGF stimulation leads to a sustained activation profile of 
EGFR-mCitrine already peaking 2 min after EGF addition (Figure 4.11 B). This is contrary to 
the transient phosphorylation profile obtained by western blot analysis of endogenous EGFR 
in BJ cells (Figure 4.10). A possible explanation for this can be a limited access of PTPs to its 
specific EGFR phosphorylation site or ectopic expression of the receptor overcomes the 
endogenous PTP activity upon EGF stimulation and the receptor stays phosphorylated for a 
longer time course. However, no significant difference between wt and G12V cells was 
detectable upon EGF stimulation as already observed before (Figure 4.10, Figure 4.11 B). 
Interestingly, HRas G12V transformed cells showed a detectable but non-significant increase 
in EGFR activation at basal state before addition of EGF when compared to wt cells.  
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Figure 4.11: Mapping EGFR phosphorylation upon EGF stimulation 
(A) FRET-FLIM measurement of the interaction between EGFR-mCitrine (upper row) and PTB-mCherry (not 
shown) shows spatial activation of the receptor upon EGF stimulation (100 ng/ml) in wt and G12V cells. The 
fraction of interacting molecules (α) indicates EGFR activity as shown in spatial maps (lower row) Scale bar: 
20 µm. (B) Box and whiskers graph of data represented in (A); middle line of the box represents median and box 
extends from the 25th to the 75th percentiles, whiskers indicate min and max values (nwt = 8; nG12V = 6).  
Besides higher H2O2 level in G12V cells, no significant effect on EGFR 
phosphorylation was detectable. This raises the question if the production of H2O2 upon EGF 
stimulation is indeed crucial for proper EGFR activation. To test this, we performed the same 
experiment with inhibition of NOX enzymes by pre-incubation with 10 µM DPI. Again, the 
receptor gets quickly phosphorylated with the highest activation at the PM decreasing towards 
the cell nucleus as shown before (Figure 4.12 A). Interestingly, wt cells still show a robust 
increase in α, whereas EGFR-mCitrine in G12V cells is significantly less phosphorylated when 
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treated with DPI (Figure 4.12 B). By comparing α from untreated to DPI treated cells, it was 
even more obvious that NOX inhibition and thus blocking the endogenous H2O2 production 
only decreases EGFR phosphorylation in G12V and not in wt cells (Figure 4.12 C).  At all 
measured time points after EGF stimulation, EGFR-mCitrine was significantly more 
phosphorylated in untreated G12V cells as in DPI treated cells showing that EGFR activation 
in these cells is more dependent on H2O2 production as in untransformed wt cells.  
 
Figure 4.12: EGFR phosphorylation dynamics upon treatment with DPI 
(A) FRET-FLIM measurement of the interaction between EGFR-mCitrine (upper row) and PTB-mCherry (not 
shown) shows spatial activation of the receptor upon EGF stimulation (100 ng/ml) in wt and G12V cells pre-
treated with 10 µM DPI. The fraction of interacting molecules (α) indicates EGFR activity as shown in spatial 
maps (lower row) Scale bar: 20 µm. (B) Box and whiskers graph of data represented in (A); middle line of the box 
represents median and box extends from the 25th to the 75th percentiles, whiskers indicate min and max values 
(nwt = 7; nG12V = 5). P values obtained by student’s t-test; significance level is indicated as follows: p < 0.05 (*) (C) 
Bar diagram shows difference between α mean from untreated cells minus α mean from DPI treated cells. Error 
bars represent SEM; p values obtained by student’s t-test; significance level is indicated as follows: p < 0.05 (*); 
n.s. = not significant 
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To sample more cells and to get a more detailed picture about the spatial regulation of 
EGFR phosphorylation, we performed FRET-FLIM experiments in fixed cells using PhosTag 
labeled with Cy3.5 serving as acceptor molecule and again ectopic expression of EGFR-
mCitrine as donor molecule. In contrast to PTB, PhosTag binds to all phosphorylated amino 
acid residues including tyrosines, serines and threonines127.  
BJ cells were again stimulated with 100 ng/ml EGF and α was obtained for pre-
stimulated cells and 1 min and 5 min after stimulation (Figure 4.13 A). In line with the live 
cell experiments, EGFR-mCitrine gets quickly phosphorylated upon EGF stimulation with 
high activity at the PM that declines towards the cell interior (Figure 4.13 A). To spatially 
resolve the fraction of phosphorylated EGFR, all cells were segmented into 8 radial profiles by 
normalizing the distances between the PM and the nuclear membrane (Figure 4.13 B). By 
plotting the mean α of each radial bin for all measured cells, we could show that EGFR 
phosphorylation is always highest close to the PM and declines drastically towards the nucleus 
(Figure 4.13 C). Even in unstimulated cells, in which the overall phosphorylation was 
relatively low, a weak phosphorylation gradient was detectable for both cell types. 
Comparison of the spatial EGFR phosphorylation profile of both cell types revealed no 
difference at early time points after EGF stimulation. Only at basal state, EGFR showed a weak 
pre-activation in G12V cells that was not apparent in wt cells (Figure 4.13 C). The same trend 
was detected in the live cell experiments when comparing α values at basal state (Figure 4.11). 
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Figure 4.13: Spatial-temporal detection of EGFR-mCitrine phosphorylation 
(A) FRET-FLIM measurement of the interaction between EGFR-mCitrine and PhosTag-Cy3.5 detecting EGFR 
phosphorylation upon EGF stimulation (100 ng/ml) for indicated time points in fixed BJ cells. Left panel shows 
representative images for wt cells and right panel for G12V cells; upper row: EGFR-mCitrine, middle row: 
PhosTag-Cy3.5, lower row: spatial distribution of interacting fraction (α).	  Scale	  bar:	  20	  µm	  (B)	  Presentation	  of	  extracting	  8	  normalized	  radial	  profiles	  from	  the	  PM	  to	  the	  nuclear	  membrane	  for	  each	  cell.	  Mean	  α	  from	  each	  bin	  can	   then	  be	  plotted	  resulting	   in	  a	  histogram	  representing	  α	   in	  space	  per	  cell	   (C)	  Graphs	  show	  spatial	  distribution	  of	  EGFR	  phosphorylation	  for	  indicated	  time	  points	  after	  EGF	  administration	  for	  wt	  and	  G12V	  cells.	  Each	  point	   represents	  mean	  α	   	  ± SEM for at least 17 cells per time point and cell type obtained 
from 4 independent experiments. 
In summary, we could show that the temporal phosphorylation profiles of EGFR are 
very similar between wt and G12V cells after EGF stimulation. However, EGFR 
phosphorylation at basal state seems to be increased in G12V cells. In addition, full EGFR 
activation in G12V cells is more dependent on functional H2O2 production as in wt cells. 
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4.2.2 Autonomous EGFR activation in BJ cells 
In addition to ligand-induced EGFR activation, it was also shown that EGFR can be 
activated in an autonomously, ligand-independent way86,128. When EGFR gets activated in the 
absence of ligand, it is mostly in a monomeric state and fails to form active, asymmetric 
dimers80. This also illustrates that the phosphorylated monomer represents a different 
signaling entity than the ligand-activated dimer. Since we observed an elevated basal EGFR 
activation in G12V cells, we investigated ligand-independent, autonomous receptor 
phosphorylation. Therefore we treated BJ cells with exogenous H2O2, which leads to a global 
oxidation and thus transient inhibition of PTPs resulting in EGFR phosphorylation86. EGFR 
activation was mapped by western blot analysis either by detection of phosphorylated Y1068 
(Figure 4.14 B), the binding site for the adaptor protein Grb2, or by detection of the total 
tyrosine phosphorylation of immunoprecipitated EGFR (Figure 4.14 A). Interestingly, low 
H2O2 doses led to EGFR phosphorylation in G12V cells whereas EGFR phosphorylation in wt 
cells still remained at basal level. In general, this shows that basal kinase activity of EGFR is 
sufficient for receptor activation upon PTP inhibition. The threshold for autonomous EGFR 
activation is lower in G12V cells, possibly provoked by the higher endogenous H2O2 level, 
which are adding up with the extracellular applied H2O2 concentrations.  
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Figure 4.14: Autonomous EGFR activation induced by extracellular H2O2 
(A) Detection of phosphorylated EGFR by western blot analysis upon treatment with indicated H2O2 doses for 5 
min. Endogenous EGFR was immunoprecipitated from wt and G12V cell lysates with anti-EGFR antibody and 
IP was probed with a generic phospho-tyrosine antibody (pY72) and anti-EGFR. Graph on the right shows mean 
± SEM of pTyr/EGFR ratio plotted against H2O2 dose from three independent experiments. P values were 
calculated by Student’s t test. (B) Detection of EGFR’s pY1068 by western blot analysis upon treatment with 
indicated H2O2 doses for 5 min. Graph on the right shows mean ± SEM of pY1068/EGFR ratio plotted against 
H2O2 dose from three independent experiments. P values were calculated by Student’s t test. 
 
EGFR activation coupled to PTP inhibition by H2O2 creates a reaction network that 
responds in a switch-like manner when treated with a certain threshold concentration of 
ligand86. Stimulation with a saturating EGF concentration did not amplify EGFR 
phosphorylation in G12V cells, despite higher H2O2 levels at basal state (Figure 4.1) and upon 
EGF stimulation (Figure 4.8). To test if a higher endogenous H2O2 concentration in G12V 
cells decreases PTP activity and thus lowers the activation threshold for EGFR, we performed 
EGF dose response experiments and analyzed them via western blots (Figure 4.15). In 
addition to the total tyrosine phosphorylation of EGFR as probed with PY72 antibody, 
phosphorylation of the binding sites for the E3 ligase c-Cbl (Y1045) and for Grb2 (Y1068) 
were detected.  
Comparison between wt and G12V cells revealed that EGFR phosphorylation as 
detected by PY72 and pY1045 seems to respond at a lower EGF threshold in wt cells but with 
a more gradual response (Figure 4.15 A, B). The EGF dose response in G12V cells acts more 
in switch-like manner as shown by a steeper slope compared to wt cells, both for PY72 and 
pY0145. Phosphorylation of Y1068 is slightly higher at low doses in G12V cells but activation 
threshold and phosphorylation level at high doses are nearly the same between both cell types 
(Figure 4.15 C).  
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Figure 4.15: EGFR phosphorylation dose response curves in BJ cells 
(A) Detection of phosphorylated EGFR by Western blot analysis upon addition of indicated EGF doses for 5 
min. Endogenous EGFR was immunoprecipitated from wt and G12V cell lysates with anti-EGFR and IP was 
probed with a generic phospho-tyrosine antibody (pY72) and anti-EGFR. Graph on the right shows mean ± SEM 
of pTyr/EGFR ratio plotted against EGF dose from three independent experiments. (B) Detection of pY1045 by 
Western blot analysis upon addition of indicated EGF doses for 5 min. Graph on the right shows mean ± SEM of 
pY1045/EGFR ratio plotted against EGF dose from two independent experiments. (C) Detection of pY1068 by 
Western blot analysis upon addition of indicated EGF doses for 5 min. Graph on the right shows mean ± SEM of 
pY1068/EGFR ratio plotted against EGF dose from three independent experiments. 
 
In addition to the biochemical detection of EGFR activation at endogenous level, 
single cell phosphorylation was analyzed in dependence of the EGFR expression level using 
immunocytochemistry. Therefore, EGFR-mCitrine was overexpressed in wt and G12V cells 
and phosphorylation of Y845, Y1045 and Y1068 was visualized with specific antibodies. Both 
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ligand-independent and EGF-induced receptor activation was investigated and compared 
between both cell types.  
By ectopic expression of EGFR-mCitrine, a wide range of receptor expression levels 
was generated for both cell types (Figure 4.16 A). Plotting the pY845/EGFRmCitrine 
fluorescence ratio against EGFR-mCitrine fluorescence intensity showed that a broad range of 
different EGFR expression levels triggered ligand-independent receptor activation in both cell 
types with a high cell-to-cell variance (Figure 4.16 B). Upon stimulation with 100 ng/ml EGF 
for 5 min, relative phosphorylation of Y845 increased, in particular for cells with lower 
expression levels (Figure 4.16 B). In order to enable a better comparison of these data, values 
of single cells were binned and averaged for all conditions (Figure 4.16 C). Ligand-
independent phosphorylation of Y845 occurred at high receptor expression for wt and G12V 
cells indicating that at high density EGFR activity overcomes endogenous PTP activity. The 
correlation of EGFR expression to Y845 phosphorylation was nearly linear and at high 
receptor expression phosphorylation levels were comparable to that of EGF stimulated cells 
(Figure 4.16 C). In addition, the relative phosphorylation of Y845 was always elevated in 
G12V cells when compared to wt cells indicating a lower threshold for autonomous EGFR 
activation as shown before when cells were treated with exogenous H2O2 (Figure 4.14). Upon 
EGF stimulation, phosphorylation of Y845 was independent of the EGFR expression level for 
both cell types, showing that ligand stimulation leads to full receptor activation even at low 
receptor density. Again, the relative phosphorylation was increased in G12V cells compared to 
wt cells, indicating that autocatalytic activation of EGFR is higher upon EGF stimulation.   
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Figure 4.16: Spontaneous and EGF-induced Y845 phosphorylation in response to EGFR expression 
(A) Representative images of ligand-independent and ligand-induced Y845 phosphorylation in response to 
EGFR-mCitrine expression in wt and G12V cells. Upper row shows EGFR-mCitrine fluorescence, middle row 
pY845 as detected by immunostaining with anti-pY845 antibody and lower row shows merged images. Scale bar: 
50 µm (B) Single cell data (black dots) and binned averages ± SEM (red line) of immunostaining showed in (A). 
(C) Plot shows binned means ± SEM of single cell data representing relative phosphorylation (mean Fl intensity 
of pY845-antibody/EGFR-mCitrine) of pY845 versus EGFR-mCitrine expression (solid lines: pre-; dashed lines: 
5 min post-stimulation with 100 ng/ml EGF) 
Autophosphorylation of the tyrosine 1045 triggers c-Cbl binding und thus indicates 
EGFR ubiquitination, which initiates receptor internalization and degradation129. In contrast 
to Y845 phosphorylation, pY1045 seems to be much more dependent on ligand stimulation. 
Phosphorylation was clearly higher in EGF treated cells, as obtained from the performed 
immunostainings (Figure 4.17 A) and single cells analysis (Figure 4.17 B). Even at high 
receptor expression level, no clear increase in phosphorylation was detectable for 
unstimulated cells. Upon EGF stimulation, a clear increase of Y1045 phosphorylation was 
detectable, which is not increasing with higher receptor expression levels (Figure 4.17 B). In 
addition, relative phosphorylation upon EGF stimulation was again higher in G12V cells as in 
wt cells. In summary, this indicates that the site Y1045 is not efficiently phosphorylated in the 
autonomously activated monomer and that EGF stimulation and dimer formation are 
necessary. Once activated with EGF, Y1045 is more sufficiently phosphorylated in G12V 
transformed cells. 
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Figure 4.17: Spontaneous and EGF-induced Y1045 phosphorylation in response to EGFR expression 
(A) Representative images of ligand-independent and ligand-induced Y1045 phosphorylation in response to 
EGFR-mCitrine expression in wt and G12V cells. Upper row shows EGFR-mCitrine fluorescence, middle row 
pY1045 as detected by immunostaining with anti-pY1045 antibody and lower row shows merged images. Scale 
bar: 50 µm (B) Single cell data (black dots) and binned averages ± SEM (red line) of immunostaining showed in 
(A). (C) Plot shows binned means ± SEM of single cell data representing relative phosphorylation (mean Fl 
intensity of pY1045-antibody/EGFR-mCitrine) of pY1045 versus EGFR-mCitrine expression (solid lines: pre-; 
dashed lines: 5 min post-stimulation with 100 ng/ml EGF) 
 
Phosphorylation of the EGFR site Y1068 serves as docking site for the adaptor protein 
Grb2, which transduces the signal from the activated receptor to several downstream 
molecules such as Ras91. In unstimulated cells, the phosphorylation level of Y1068 increased in 
dependence of the EGFR expression level in both cell types but more pronounced in G12V 
cells (Figure 4.18 B). Unfortunately, the number of cells with high expression level was low so 
that data became noisy. Anyways, G12V cells showed clearly a higher Y1068 phosphorylation 
than wt cells at low EGFR expression levels in the absence of ligand (Figure 4.18 C). When 
stimulated with EGF, Y1068 was more efficiently phosphorylated at low EGFR expression 
levels in G12V cells. In contrast, both cell types showed a similar phosphorylation ratio at 
higher receptor expression levels indicating saturation. 
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Figure 4.18: Spontaneous and EGF-induced Y1068 phosphorylation in response to EGFR expression 
(A) Representative images of ligand-independent and ligand-induced Y1068 phosphorylation in response to 
EGFR-mCitrine expression in wt and G12V cells. Upper row shows EGFR-mCitrine fluorescence, middle row 
pY1068 as detected by immunostaining with anti-pY1068 antibody and lower row shows merged images. Scale 
bar: 50 µm (B) Single cell data (black dots) and binned averages ± SEM (red line) of immunostaining showed in 
(A). (C) Plot shows binned means ± SEM of single cell data representing relative phosphorylation (mean Fl 
intensity of pY1068-antibody/EGFR-mCitrine) of pY1068 versus EGFR-mCitrine expression (solid lines: pre-; 
dashed lines: 5 min post-stimulation with 100 ng/ml EGF) 
 
In summary, we could show that the activation threshold for EGF-independent 
receptor activation is lower in HRas G12V transformed cells when compared to wt cells when 
treated with H2O2 or by ectopic expression of EGFR-mCitrine. Interestingly, phosphorylation 
of different tyrosine residues varied in their ability to get phosphorylated in the absence of 
ligand indicating the distinct regulation of phosphorylation and dephosphorylation of those 
sites. When stimulated with increasing concentrations of EGF both cell types showed an 
ultrasensitive phosphorylation response for all investigated tyrosine residues. 
 
4.2.3 Activation of downstream effector molecules 
It has been shown that autonomously activated EGFR represents a different signaling 
entity than ligand activated EGFR. In general, EGFR signal transduction mainly activates the 
PI3K-AKT and Ras-ERK signaling cascades, whereby ligand-activated receptors activate both 
pathways and monomeric EGFR was shown to only signal via AKT80. Thus, we detected 
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activation of ERK and AKT in BJ cells at basal state and upon EGF stimulation with a 
saturating EGF dose (50 ng/ml) in whole cell lysates via western blot analysis. In unstimulated 
cells phospho-ERK was slightly higher in G12V cells, which is rather evoked through 
oncogenic Ras signaling itself than activated EGFR130 (Figure 4.19 A). When stimulated with 
EGF, both cell types showed nearly the same activation level of ERK consistent with similar 
Y1068 phosphorylation, the GRB2-binding site initiating ERK activation (Figure 4.10). 
Activation of AKT did not differ between wt and G12V cells at basal state. But G12V cells 
showed an elevated AKT phosphorylation in comparison to wt cells when stimulated with 
EGF (Figure 4.19 B). 
 
Figure 4.19: Basal and EGF-evoked phosphorylation of EGFR downstream effectors 
(A) Left panel shows representative western blot images of ERK phosphorylation detected at basal level and upon 
EGF stimulation (50 ng/ml) for 10 min in BJ whole cell lysates. Right panel shows mean of pERK over total ERK 
± SEM for two independent experiments. (B) Left panel shows representative western blot images of AKT 
phosphorylation detected at basal level and upon EGF stimulation (50 ng/ml) for 10 min in BJ whole cell lysates. 
Right panel shows mean of pAKT over total AKT ± SEM for two independent experiments. 
 
Since AKT activation is important for intracellular ROS activation and is thought to 
only occur at the plasma membrane131-133, we performed EGF dose response experiments and 
monitored downstream phospho-AKT. Interestingly, the activation profile of AKT differed 
significantly from the corresponding phospho-EGFR profile in both wt and G12V cells 
(Figure 4.20). AKT activation in wt cells peaked already at an EGF concentration of 2 ng/ml 
and decreased at higher doses by following rather an unsymmetrical Gaussian than a 
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sigmoidal curve as obtained for phospho-EGFR. In contrast, AKT activation in G12V cells 
plateaued between 2 and 10 ng/ml EGF and did not show a significant decrease at higher EGF 
concentrations (Figure 4.20). This is in line with the before performed experiment, where 
AKT phosphorylation was higher in G12V cells as in wt cells when stimulated with a 
saturating EGF concentration (Figure 4.19). In summary, AKT activation in wt cells was 
higher at low doses of EGF when mainly monomers are activated at the PM and 
internalization is not accelerated by ubiquitination. At higher EGF doses, AKT activation 
decreased possibly through increased internalization of phospho-EGFR dimers and a shift to 
ERK activation. This is contrary to AKT activation in G12V cells. Here, we found that AKT 
phosphorylation stays relatively low until the threshold EGF concentration of 2-10 ng/ml is 
reached, where AKT reaches full activation. Higher EGF concentrations did not lead to a 
decreased AKT activation as shown for wt cells.  
 
 
Figure 4.20: AKT phosphorylation profile upon stimulation with different EGF doses 
Detection of phosphorylated AKT by Western blot analysis upon addition of different EGF doses for 5 min in BJ 
cells. Graph on the right shows mean ± SEM of pAKT/AKT ratio plotted against EGF dose from four 
independent experiments. Significance level is indicated as follows: p < 0.05 (*) 
 
4.3 Oxidation of PTPs 
In summary, we could show that oncogenic HRas G12V leads to an increased 
production of H2O2 at basal level and upon EGF stimulation. This leads to an increased 
autonomous EGFR activation in HRas G12V transformed cells and is necessary for cellular 
survival/proliferation and full receptor activation in EGF stimulated cells. EGF time and dose 
response experiments upon EGF stimulation were similar between both cell types but G12V 
cells were more susceptible for autonomous EGFR activation as on the one hand shown by 
H2O2 treatment and on the other hand by the dependency of phospho-EGFR on the EGFR 
expression level. Since high levels of H2O2 can affect EGFR activation mainly through the 
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double negative feedback created by PTP oxidation, we wanted to assess this coupling more in 
detail and how it can influence the responsiveness of the EGFR system. 
4.3.1 Detection of PTP oxidation 
Generation of H2O2 leads to changes in signaling events by chemoselective oxidation 
of cysteine residues in proteins thereby altering their activity status. It is well established that 
classical PTPs, as counterparts of RTK signaling, are one of the major targets of H2O2 
signaling134. Oxidation of the catalytic cysteine in the PTPs active site leads to the inhibition of 
protein activity42. Here we used dimedone-derivatization of sulfenic acid, the first 
intermediate generated by H2O2, to monitor protein oxidation. First, we treated the catalytic 
domain of PTP1B (PTP1Bc) in vitro with increasing H2O2 concentrations either in the 
presence of dimedone or DMSO. Subsequent visualization by western blots and incubation 
with anti-dimedone antibody62 showed that PTP1B indeed can be oxidized and that oxidation 
increases significantly with higher H2O2 concentrations (Figure 4.21). In contrast to 
dimedone, DMSO incubation didn’t give a significant signal proving that dimedone binds to 
oxidized PTP1Bc and can be visualized with the anti-dimedone antibody.  
 
 
Figure 4.21: Oxidation of the catalytic domain of PTP1B in vitro   
Catalytic domain of PTP1B (PTP1Bc) was treated with indicated concentrations of H2O2 in the presence of 5 
mM dimedone or the equivalent volume DMSO. Fractions of oxidized PTP1Bc (right graph) were analyzed by 
western blot with the α-dimedone antibody. Graph shows mean ± SEM of dimedone/PTP1B ratio from three 
independent experiments. P values for comparison between dimedone and DMSO were calculated by Student’s t 
test otherwise with two-way ANOVA.  
 
Next, we sought to test if this approach is also suitable for the detection of oxidized 
proteins in cells. Therefore, BJ wt cells were treated with 1mM H2O2 either in the presence of 
dimedone or DMSO. To test how efficient Dimedone enters the cells and binds sulfenic acid, 
we used an incubation time of 10 min and 30 min and detected oxidation subsequently via 
western blot. As shown before in the in vitro assay, DMSO incubation just gave a minor 
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background signal, which indicates a low unspecific binding of the antibody and only 
incubation with dimedone led to a detectable signal (Figure 4.22 A). Incubation of 30 min and 
stimulation with 1 mM H2O2 gave a higher signal, due to the accumulation of oxidized 
proteins by the irreversible reaction with dimedone. Equal loading of protein was confirmed 
by detection of the housekeeping protein GAPDH (Figure 4.22 A). Since detection of sulfenic 
acid in whole cell lysates gives a signal for all oxidized proteins in the cell, we performed 
immunoprecipitation experiments for endogenous PTP1B and checked for its oxidation. 
Treatment with H2O2 led to a recognizable band shift when incubated with an antibody 
against PTP1B and incubation with dimedone gave a detectable band for sulfenic acid (Figure 
4.22 B). Dimedone was incubated for either 10 min or 30 min on cells but for PTP1B 
oxidation no significant difference was detectable. Therefore, dimedone was incubated on 
living cells for 10 min in all further experiments since the shorter incubation time matches 
also better with the quick accumulation of EGF-evoked H2O2 (Figure 4.7, Figure 4.8). 
 
 
Figure 4.22: Detection of dimedone-derivatized proteins in BJ cells 
(A) Detection of oxidized proteins in whole cell lysates of BJ cells treated as indicated. Oxidation of proteins was 
determined by western blot and incubation with the anti-dimedone antibody. Equal loading of proteins was 
confirmed with anti-GAPDH antibody. (B) IP of endogenous PTP1B from BJ cell lysates treated as indicated and 
probed with anti-dimedone and anti-PTP1B antibody. 
 
We continued to investigate overexpressed PTP1B-mCitrine and SHP2-mCitrine, two 
PTPs that are known to be oxidized40, and used dimedone for detection of sulfenic acid 
formation in BJ wt and G12V cells. Ectopic phosphatase expression has the advantage to be 
more independent in choosing antibodies due to the possibility of detecting both PTPs with 
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an anti-GFP antibody. In addition, a high expression level of each PTP increases substrate 
availability for oxidation, optimizing the signal-to-noise ratio.  
 First, PTP1B-mCitrine was investigated since we detected PTP1B oxidation already in 
vitro and in vivo. As before, treatment with H2O2 induced an increase in the appearing 
dimedone bands indicating the formation of sulfenic acid for several proteins. GAPDH, a 
protein highly susceptible for non-GF evoked oxidation135, shows a high increase in oxidation 
for both cell types independently of PTP1B-mCitrine or SHP2-mCitrine overexpression 
(Figure 4.23). This proves that the here-used assay works for the detection of protein 
oxidation in general. The dimedone signal for PTP1B-mCitrine is lower than for GAPDH but 
the ratio of total over oxidized protein revealed a robust increase upon H2O2 treatment in both 
cells with a lower threshold in G12V cells (Figure 4.23 A). Detection of SHP2-mCitrine 
oxidation showed a similar trend but a higher fold-increase when compared to PTP1B-
mCitrine oxidation (Figure 4.23 B). 
 
 
Figure 4.23: Oxidation of ectopically expressed PTPs in BJ cells  
(A) Western blot analysis of oxidized proteins in BJ whole cell lysates overexpressing PTP1B-mCitrine. Upper 
image shows total oxidation as detected by incubation with anti-dimedone antibody; a pink box marks PTP1B-
mCitrine and GAPDH bands. Middle and lower image shows merged bands of anti-dimedone overlaid with 
anti-GFP detecting PTP1B-mCitrine and anti-GAPDH, respectively. Lower panel shows means ± SEM of relative 
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increase of PTP1B-mCitrine oxidation for two independent experiments. P values were calculated via two-way 
ANOVA. (B) Western blot analysis of oxidized proteins in BJ whole cell lysates overexpressing SHP2-mCitrine. 
Upper image shows total oxidation as detected by incubation with anti-dimedone antibody; a pink box marks 
SHP2-mCitrine and GAPDH bands. Middle and lower image shows merged bands of anti-dimedone overlaid 
with anti-GFP detecting SHP2-mCitrine and anti-GAPDH, respectively. Lower panel shows means ± SEM of 
relative increase of SHP2-mCitrine oxidation for two independent experiments. P values were calculated via two-
way ANOVA.  
 
However, detection of oxidized PTPs in blots with the anti-dimedone antibody gave 
quite noisy signals, most likely caused by different expression levels, variations in the 
dimedone reaction and the unspecificity of antibody binding. In order to improve detection of 
oxidized proteins, we tested dimedone analogues, which are linked to different functional 
groups that allow alternative detection methods. First, we tested DCP-Bio1, a biotinylated 
derivative of Dimedone60. As before, recombinant PTP1Bc was used for in vitro oxidation and 
subsequent labeling with DCP-Bio1. The labeling reaction was quantified via western blot by 
coupling to IR-labeled Streptavidin (STV), which is comparable to immunodetection with IR-
labeled secondary antibodies used before. In contrast to the reaction with unmodified 
dimedone, DCP-Bio1 did not show an increase in signal when PTP1Bc was incubated with 
increasing H2O2 concentrations (Figure 4.24 A). We speculated that increased affinity of the 
biotin-streptavidin binding saturated the signal already without addition of H2O2 so that a 
further increase upon oxidation was not detectable. Therefore, DCP-Bio1 concentration was 
lowered to 1 mM and 0.5 mM and oxidation was again detected via labeled-Streptavidin. 
However, even the lower DCP-Bio1 concentrations gave a high background signal and no 
increase was measured upon treatment with H2O2 (Figure 4.24 B). 
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Figure 4.24: Testing different dimedone variants for protein oxidation in vitro 
(A) PTP1Bc was treated with indicated concentrations of H2O2 in presence of 5 mM dimedone, 5 mM DCP-Bio1 
or the equivalent volume DMSO. Fractions of oxidized PTP1Bc (right graph) were analyzed by Western blot 
with the anti-dimedone antibody or IRDye-800 STV. Graph on the right shows mean ± SEM of 
dimedone/PTP1Bc ratio from one experiment. (B) Western blot of PTP1Bc treated as indicated and incubated 
with different DCP-Bio1 concentrations for detection of oxidation. Labeling of DCP-Bio1 was detected with 
IRDye-800 STV. Graph on the right shows mean ± SEM of DCP-Bio1/PTP1Bc ratio from one experiment. 
 
Since in vitro oxidation of PTP1Bc is really fast and the required H2O2 concentration 
and reaction time are not comparable to oxidation dynamics in cells, we repeated the DCP-
Bio1 experiment in BJ cells. Unmodified dimedone and detection with anti-dimedone 
antibody was used as positive control to ensure that protein oxidation has worked. As for 
PTP1Bc, again no increase in the DCP-Bio1-STV signal was detectable upon treatment with 1 
mM H2O2 in both cell lines (Figure 4.25 A). In contrast, the anti-dimedone signal and in 
particular the 37 kDa band corresponding to GAPDH increased upon treatment with H2O2 
indicating that protein oxidation upon administration of H2O2 took place. Since we wanted to 
investigate oxidation of proteins in a spatial-temporal manner, we continued with in situ 
experiments. Therefore, BJ cells were incubated with 10 µM DCP-Bio1, followed by staining 
of the compound after fixation with Cy3.5-labeled STV. We speculated that Cy3.5 intensity 
increases upon treatment with H2O2 or EGF but high background staining of the nucleus and 
intracellular membranes made a comparison based on fluorescence intensity infeasible 
(Figure 4.25 B). For a quantitative analysis, we moved to a FRET-FLIM approach based on 
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overexpression of PTP1B-mCitrine in BJ wt cells. Although we could detect a lifetime 
decrease upon incubation with STV-Cy3.5 in comparison to the donor only control, this effect 
seems to be independent of protein oxidation since incubation with STV-Cy3.5 in the absence 
of DCP-Bio1 gave the same staining pattern and comparable lifetime values (Figure 4.25 C). 
Thus, we concluded that DCP-Bio1 is not working for the detection of oxidized PTPs and in 
addition, in-cell staining with labeled STV is not suitable for further experiments due to high 
background staining.  
 
 
Figure 4.25: Testing DCP-Bio1 for detection of protein oxidation 
(A) Western blot of BJ total cell lysates comparing detection of oxidized proteins with either dimedone (5 mM) 
or DCP-Bio1 (5 mM) in cells treated as indicated. Dimedone-derivatized proteins were detected with anti-
dimedone antibody and DCP-Bio1-derivatized proteins with IRDye800-labeled STV. Equal protein loading was 
ensured with anti-GAPDH detection. (B) Staining of BJ cells treated as indicated with Cy3.5 labeled STV upon 
incubation with DCP-Bio1. Scale bar 30 µm (C) FRET-FLIM of PTP1B-mCitrine and DCP-Bio1 labeled with 
Cy3.5 tagged STV in BJ wt cells treated as indicated. Left panel shows means ± SEM for 4-5 cells per condition. 
Scale bar: 30 µm 
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To overcome the problem of unspecific STV-Cy3.5 binding to endogenous proteins 
and membranes, we tested a dimedone analogue, which is directly labeled with the fluorescent 
dye Rhodamine called DCP-Rho160. This probe is cell-permeable and thus incubation on 
living cells without prior fixation or permeabilization, which would disrupt the cellular redox 
state, can be retained. Moreover, Rhodamine has a similar fluorescence spectrum as Cy3.5, 
which makes it also suitable as acceptor molecule for mCitrine-tagged proteins. First, we 
tested DCP-Rho1 in a simple staining experiment, in which BJ wt cells were treated with 
different H2O2 concentrations or pre-treated with DPI (Figure 4.26 A). Incubation of cells 
with DCP-Rho1 still led to a distinct staining of endomembranes but unlike to DCP-Bio1 
labeled with STV-Cy3.5 staining intensity increased with H2O2 treatment indicating a higher 
abundance of oxidized proteins (Figure 4.25 B). For quantification, we tested DCP-Rho1 in a 
FRET-FLIM approach in H2O2 treated cells. The cytoplasmic PTP SHP2-mCitrine was used as 
donor molecule, which did not co-localize with the DCP-Rho1 on endomembranes like 
PTP1B lowering the chance of unspecific FRET. Since cells were fixed, we performed 
acceptor-photobleaching to reveal the possible FRET between DCP-Rho1 and SHP2-mCitrine 
(Figure 4.26 B). However, SHP2-mCitrine lifetime was around 3 ns even before acceptor-
photobleaching and did not change after bleaching indicating no interaction between both 
fluorophores.  
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Figure 4.26: Imaging of DCP-Rho1 to reveal protein oxidation in situ 
(A) Representative images of BJ wt cells treated as indicated and then incubated with 5 µM DCP-Rho1 for 
another 10 min followed by fixation with PFA. Scale bar 20 µm (B) FRET-FLIM of wt cells expressing SHP2-
mCitrine and stained with DCP-Rho1 treated with 1 mM H2O2. Left panel shows representative fluorescence 
images of SHP2-mCitrine (first column), fluorescence lifetime (τ;	   second	   column) and DCP-Rho1 (third 
column) prebleach (first row) and after 30 min of acceptor-photobleaching (second row). Right panel shows τ-
histogram pre- and postbleach for cell represented in images on the left. Scale bar 20 µm 
4.3.2 Spatial-temporal detection of SHP2-oxidation 
Since unmodified dimedone was suitable for the detection of oxidized PTP1Bc in vitro 
and also showed promising results in biochemical assays in vivo, we continued with a different 
probe called DYn-2 that is alkyne-modified and suitable for click-chemistry40.  In contrast to 
DCP-Bio1 and DCP-Rho1, DYn-2 does not bear a bulky detection tag that can limit cell 
permeability and access to the catalytic cleft of PTPs, which is the main protein group we want 
to investigate here. In addition, an alkynyl-chemical reporter can be labeled with any azide-
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modified detection tag in fixed cells, making DYn-2 suitable for both - biochemical and 
imaging-based assays.  
For the RTK-PTP reaction network it has been shown that spatial partitioning of 
active signaling molecules is important to allow robust RTK activation while preventing 
autonomous activation in the absence of ligand80,81. Therefore, PTP oxidation is thought to be 
confined to compartments where EGFR gets phosphorylated. To investigate this spatially 
controlled PTP oxidation by GF-evoked H2O2, we want to set up an imaging approach to 
detect PTP oxidation via FLIM. The ectopic expression of a specific PTP tagged to mCitrine 
combined with the labeling of DYn-2 with a red fluorescent dye should result in FRET when 
the observed PTP is oxidized (Figure 4.27 A). First, we tested the labeling of DYn-2 with 
different acceptor molecules via cupper-catalyzed click-chemistry and checked by comparing 
these cells with just DMSO treated cells for the lowest background fluorescence (Figure 4.27 
B). We decided to continue with Alexa594-Azide, which showed nearly no background in the 
DMSO control but gave a strong signal when DYn-2 was pre-incubated on live cells (Figure 
4.27 B). In comparison to the previous two staining approaches with DCP-Bio1 and DCP-
Rho1, DYn-2 labeled via click chemistry showed far less background staining of 
endomembranes indicating less unspecific binding of the probe and the dye itself. 
 
Figure 4.27: Development of a DYn-2 based approach for imaging protein oxidation  
(A) Upper diagram illustrates the labeling of DYn-2 via cupper-catalyzed click-chemistry reaction with a red 
fluorescent dye serving as acceptor molecule. Lower panel shows binding of DYn-2 to oxidized PTPs tagged with 
a yellow fluorescent protein serving as donor fluorophore. Close proximity of donor and acceptor leads to FRET 
between both molecules and a lifetime drop of the donor detectable via FLIM. (B) Testing of different azide-
modified acceptor molecules for the click-chemistry reaction with DYn-2. Live cells were incubated with either 
DYn-2 or the equivalent amount of DMSO, fixed and stained with the indicated dyes. Scale bar: 30 µm 
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Next, we tested if the combination of DYn-2 – Alexa594Az with mCitrine tagged PTPs 
is suitable for FRET-FLIM experiments. We started with SHP2 since we could show before 
that this PTP is susceptible to oxidation and also previous studies reported oxidation upon 
EGF treatment40.  In BJ wt cells, incubation with only the dye without pre-treatment with 
DYn-2 did not show any significant staining and the mCitrine lifetime was not changed 
(Figure 4.28 A). When cells were pre-incubated with DYn-2 but unstimulated, the mCitrine 
lifetime decreased slightly compared to the DMSO treated cells. A clear lifetime reduction was 
detected when cells were treated with 0.5 mM H2O2, showing that this approach is suitable to 
detect SHP2 oxidation in cells (Figure 4.28 A). Next, we just compared the DYn-2 – 
Alexa594Az fluorescence intensity (Fl Int) to check if conventional imaging of DYn-2 binding 
itself is sufficient for the quantification of protein oxidation in general. However, DYn-2 – 
Alexa594Az intensity did not increase upon H2O2 treatment indicating that FRET-FLIM is 
necessary to untangle oxidation of a specific protein from global protein oxidation (Figure 
4.28 B). To exclude nonspecific FRET arising from random collisions and/or unspecific 
associations of donor (D) and acceptor (A) molecules, we plotted mCitrine lifetime (τ) against 
the ratio of A over D fluorescence intensity (Figure 4.28 C). Both for unstimulated and H2O2 
treated cells no correlation between τ and A/D Fl intensity was detectable indicating that the 
measured drop in τ is induced by a specific interaction between A and D molecules. In 
addition, treatment with H2O2 decreased τ to significant lower levels when compared to 
unstimulated cells proving that we indeed detected SHP2 oxidation (Figure 4.28 C). 
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Figure 4.28: Specific detection of SHP2 oxidation with DYn-2 
(A) FRET-FLIM of BJ wt cells expressing SHP2-mCitrine incubated either with DYn-2 or DMSO and 
subsequently stained with Alexa594Az. Representative fluorescence images of SHP2-mCitrine (first row), 
Alexa594Az (second row), and fluorescence lifetime (τ) of SHP2-mCitrine (third row) of cells treated as 
indicated. Scale bar: 20 µm (B) Plot shows mean ± SEM of fluorescence intensity (Fl Int) of Alexa594Az of either 
unstimulated cells or cells treated with 0.5 mM H2O2. (C) Graph shows τ versus Alexa594Az/mCitrine ratio of 
single cells that were either unstimulated or treated with 0.5 mM H2O2 in the presence of DYn-2.	  
 
To investigate if increased endogenous H2O2 level as caused by constitutively active 
HRas G12V (Figure 4.1, Figure 4.8) influence PTP oxidation and thus increase autonomous 
EGFR activation, we detected SHP2 oxidation in BJ wt and G12V cells with the above 
described method. In both cell types treatment with 0.1 mM and 0.5 mM H2O2 led to a 
significant decrease in τ when compared to untreated cells (Figure 4.29 A, B). When 2.5 mM 
H2O2, a concentration high above the physiological level, was applied to cells τ increased again 
and reached levels comparable to untreated cells. This might be caused by the overoxidation 
of the thiol of the catalytic cysteine to sulfinic or sulfonic acid, which both do not react with 
DYn-2 or any other dimedone derivative136. G12V cells showed in total a higher heterogeneity 
in SHP2 oxidation as wt cells pointing to a wider range of endogenous H2O2 levels (Figure 
4.29 B). In addition, 0.5 mM H2O2 still led to a decrease of τ in G12V cells, whereas the same 
concentration led to an increase of τ in wt cells when compared to 0.1 mM H2O2 (Figure 4.29 
B). This observation is in agreement with the HyPer3 experiments, which were also pointing 
to a more potent antioxidant system in G12V cells leading to a higher tolerance towards 
enhanced H2O2 concentrations (Figure 4.4, Figure 4.5). A direct comparison of both cell types 
   89 
revealed that oxidation of SHP2 is higher in G12V cells at basal state and when treated with 
0.5 and 2.5 mM H2O2 (Figure 4.29 C).  
To investigate the proposed coupling between RTK activation and PTP inhibition, we 
stimulated both cell lines with EGF and detected SHP2 oxidation. Indeed, EGF stimulation led 
to the oxidation of SHP2 in both cell types, confirming the recursive interaction between 
EGFR activation and PTP inhibition. Again, the variation in SHP2 oxidation was far lower in 
wt cells when compared to G12V cells, possibly caused by a wider range of endogenous H2O2 
concentrations generated by constitutively active HRas (Figure 4.29 B). However, the 
oxidation and thus inactivation of SHP2 was on average not higher in G12V transformed cells 
(Figure 4.29 C).  
 
 
Figure 4.29: SHP2 oxidation in BJ cells upon H2O2 and EGF treatment 
(A) Representative fluorescence images of SHP2-mCitrine (first row), Alexa594Az (second row), and 
fluorescence lifetime (τ) of SHP2-mCitrine (third row) showing SHP2-mCitrine oxidation in wt (left panel) and 
G12V cells (right panel) treated as indicated. Scale bar: 20 µm (B) Quantification of τ	   in	   single	   cells	   upon	  addition	  of	  different	  concentrations	  of	  H2O2	  or	  100	  ng/ml	  EGF	  for	  10	  min.	  Horizontal	  line	  shows	  mean	  ± 
SD; two-way ANOVA was used for statistical tests. (C) Bar diagram showing mean ± SEM of τ from single cells 
plotted in (B) for direct comparison of oxidized SHP2-mCitrine between wt and G12V cells; p values were 
calculated by Student’s t test.  
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To check if the here measured oxidation of SHP2 reflects indeed oxidation of the 
catalytic cysteine and thus leads to the inhibition of this PTP, we performed the same 
experiment with the catalytically inactive mutant (C/S)137. The staining intensity of DYn-2 – 
Alexa594Az was comparable to the SHP2-wt experiments showing once more that the pool of 
oxidized proteins in the cell is quite high and oxidation of specific proteins are hard to detect 
(Figure 4.29 A, Figure 4.30 A). However, in contrast to SHP2-wt, treatment with different 
H2O2 concentrations did not change τ of SHP2-C/S-mCitrine, indicating that we detected 
indeed oxidation of the catalytic cysteine in SHP2 (Figure 4.30).  
 
Figure 4.30: No oxidation detectable for SHP2-C/S mutant 
(A) Representative fluorescence images of SHP2-C/S-mCitrine (first row), Alexa594Az (second row), and 
fluorescence lifetime (τ) of SHP2-C/S-mCitrine (third row) in wt (left panel) and G12V cells (right panel) treated 
as indicated. (B) Plot shows mean ± SEM for wt SHP2 (black, data from Figure 4.29) and C/S mutant (grey) for 
BJ wt cells on the left and G12V cells on the right for different H2O2 concentrations (n = min. 6 cells per 
condition).  
In summary, we could show that the above-described approach is suitable for the 
detection of SHP2 oxidation and the resulting catalytic inactivation. Moreover, the data 
indicate that extracellular H2O2 and EGF-provoked H2O2 production inactivate SHP2 in both 
cell types, whereas G12V cells exhibit a higher cell-to-cell variability.  	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5 DISCUSSION 
Cellular transformation by gain of function mutations of oncogenes is one of the 
major causes of cancer development and progression. The three Ras genes, comprising KRAS, 
NRAS and HRAS, were the first oncogenes being described and making up the most 
frequently mutated gene family in human cancer138,139. However, despite the extensive research 
that is focused on inhibiting Ras or its downstream effectors, clinical trials often resulted in 
unpredictable drawbacks showing that conventional therapy approaches are often too 
simplistic for treating a complex dynamic disease such as cancer. In the last years, systemic 
approaches gained more and more attention in the development of anti-cancer treatments. 
For example, identification of unknown feedback loops, which connect signaling nodes on all 
possible levels shifted the focus from the mutated gene itself to its effects on the dynamics of 
the signaling network, thus opening the door for more successful anti-cancer strategies, such 
as combinational therapy140 and targeting of non-oncogene co-dependencies109.  
Here, we investigated how oncogenic HRas increases cellular H2O2 levels as a 
consequence of enhanced NOX activity. We showed that HRas G12V transformed cells are 
dependent on higher ROS levels and that increased production of H2O2 is affecting the RTK-
PTP reaction network making these cells more susceptible for autonomous EGFR activation. 
To identify how the EGFR-PTP network dynamics determine the EGFR phosphorylation 
response, we developed a strategy to image protein oxidation revealing SHP2 oxidation in a 
spatial-temporal manner. Increased H2O2 levels in HRas G12V transformed cells are causing a 
higher basal oxidation of SHP2, which correlates with the increased autonomous EGFR 
activation in those cells. The further investigation of PTP oxidation could give new insights 
into how the EGFR-PTP network is affected by H2O2 in general and how high levels of H2O2, 
as common in cancer cells, could modulate it. We propose to study in the future the changes 
on the network level caused by oncogenic HRas to develop new strategies for the 
pharmacological treatment of Ras-driven cancer cells.  
5.1 The spatial-temporal regulation of H2O2 production 
Several studies have shown that elevated ROS levels are frequently linked to malignant 
transformation of cells making it a common phenomenon in human cancer97,141. Initially 
disregarded as irrelevant side product of a higher cellular metabolism, the role of ROS gained 
more and more interest in the scientific field revealing that it induces signaling cascades that 
mediate the oncogenic phenotype142. It was shown that oxidation of distinct signaling proteins 
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can increase tumor angiogenesis, drives the onset of inflammation and promotes the 
conversion of fibroblasts into myofibroblasts142. Those processes ultimately lead to tumor 
growth and metastatic dissemination indicating that a further investigation of ROS signaling 
in cancer cells can be beneficial for the development of new therapeutic approaches143. 
To date, literature about the diverse roles of ROS and their function in normal and 
cancer signaling is complex and in part conflicting1,144. In this work we used isogenic cell lines 
to specifically detect the changes in ROS signaling by introducing cellular transformation via 
HRas G12V114. We showed that intracellular H2O2 levels are increased in G12V cells and that 
the production depends on functional Ras signaling that mediates the activation of NOX 
proteins (Figure 4.1). Interestingly, abrogation of Ras signaling by PalmB and NOX inhibition 
by DPI also led to a significant decrease of H2O2 levels in unstimulated wt cells, showing that 
even untransformed cells produce H2O2 via Ras-NOX signaling at basal level. These results 
support the idea of H2O2 being a crucial signaling molecule not only in malignant cells, but 
also in untransformed cells. However, effects on cellular growth after inhibiting H2O2 
production were only observed for HRas G12V transformed cells (Figure 4.2). High 
concentrations of DPI were necessary to inhibit cell growth in non-transformed cells, 
supporting the idea that ROS homeostasis is precisely balanced in transformed cells, whereas 
untransformed cells have a higher capacity for dealing with changing ROS level143,145.  
In order to fully understand the role of ROS and in particular H2O2 in normal and 
malignant cell signaling, it is necessary to consider the molecular mechanisms of oxidant 
actions. It has always been challenging to understand how target selectivity and spatial 
accumulation of H2O2 are achieved in a mainly reducing environment such as the cellular 
cytosol. With the discovery of NAPDH oxidases (NOXs) in leukocytes and later in various cell 
types, it was obvious that reactive oxidants are produced in regulated physiological 
processes146.  
In this study, we focused on the investigation of H2O2 production and its impact on 
EGFR signaling. Previous work showed that EGF stimulation leads to accumulation of H2O2, 
whereas treatment with exogenous H2O2 leads to ligand-independent EGFR activation26,86. 
Therefore, we investigated H2O2 production in dependence of the EGFR expression level 
showing that not only EGF stimulation and thus EGFR dimers, but also autonomously 
activated EGFR monomers can trigger the accumulation of H2O2 (Figure 4.3). In addition, the 
extent of H2O2 production in diverse cellular locations upon EGF stimulation was determined 
by using the genetically encoded sensor HyPer3125 that was expressed in the cytosol or tagged 
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to the PM or ER. Spatial confinement of second messenger molecules like H2O2 is one key 
aspect of defining target specificity of ROS signaling147. Interestingly, our data indicates that 
the main increase of EGF induced H2O2 occurs in the cytosol (Figure 4.6, Figure 4.7, Figure 
4.8). H2O2 produced by PM-associated NOX proteins first accumulates in the extracellular 
space and needs to diffuse back into the cell through the PM to reach intracellular target 
molecules. The H2O2 levels close to the PM possibly can not be detected with the here used 
HyPer3-TK version because it gets too fast diluted to provoke a significant change in the 
HyPer3-TK ratio. However, a better fold change upon EGF stimulation was achieved with the 
HyPer3/mCherry system, which was not tested for HyPer3-TK and HyPer3-ER. Further 
experiments with these combinations are needed to correctly compare H2O2 production in all 
three compartments. In summary, we could show though that EGF triggered a significant and 
fast increase of H2O2 in BJ cells and in MCF7 cells overexpressing EGFR. Upon EGF 
stimulation, EGFR gets internalized via packing into small endosomes, which could also serve 
as source of EGF-evoked H2O2. It was described before that activated NOX proteins could be 
also located on endosomes148, which would rather lead to a cytosolic H2O2 accumulation, as 
detected with cHyPer3. A further investigation of the H2O2 dynamics upon EGF stimulation 
with HyPer tagged to endosomes could resolve its spatial accumulation more precisely. 
However, a clear accumulation of NOX complexes was detectable at the PM in G12V 
cells indicating this compartment as main location for the increased H2O2 levels in G12V cells 
at basal level and upon EGF stimulation (Figure 4.9 C). In contrast to NOX2, the ER-
anchored NOX4 complex is constitutively active and didn’t show an elevated expression in 
HRas G12V transformed cells (Figure 4.9 B), therefore making it an unlikely source for 
stimulus-dependent H2O2 production149. The main problem in imaging H2O2 is its short-lived 
nature making a precise localization challenging even with advanced sensors like the here-
used HyPer system. A combination with new imaging approaches such as on-stage cryo-arrest 
could provide new possibilities in uncovering ROS landscapes in normal and malignant cells 
and upon stimulation150. The detection of the distinct H2O2 sources in resting cells and upon 
GF stimulation would be a major step towards understanding the spatial and temporal 
regulation of ROS signaling. Since compartmentalization is also one of the main determinants 
of signal specificity of ROS, clear source localization would narrow down possible target 
proteins.  
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5.2 The effect of oncogene-induced H2O2 on EGFR activation 
As described before, we showed that cellular transformation by HRas G12V increases 
cellular H2O2 levels both, at basal level and upon EGF stimulation. Additionally, EGFR itself 
leads to an accumulation of H2O2 when the receptor is highly overexpressed. In both cases, 
production of H2O2 seems to depend on stimulus-dependent NOX activation as shown by 
DPI treatment. Several reports document that GF evoked H2O2 production is necessary for 
inhibition of counteracting PTPs, one of the most famous target groups of ROS86,151. Elevated 
H2O2 levels should therefore increase tyrosine phosphorylation and thus receptor signaling 
activity. In case of HRas G12V transformed cells, we expected that the Ras induced H2O2 
production can affect upstream RTKs like EGFR by inhibiting PTPs.  
Therefore, we moved on to investigate EGFR activation in wt and G12V cells. 
Surprisingly, we could not detect any major differences in the EGFR phosphorylation profile 
between wt and HRas G12V transformed cells (Figure 4.10, Figure 4.11, Figure 4.13). 
However, basal EGFR phosphorylation in G12V cells was elevated, representing a higher 
activation of monomeric EGFR (Figure 4.11, Figure 4.13), which was lost upon DPI treatment 
(Figure 4.12). A higher EGFR phosphorylation in G12V cells was also observed upon 
treatment with exogenous H2O2 leading to solely autonomous receptor activation, which is 
characterized by phosphorylation of EGFR monomers (Figure 4.14)80. Various studies suggest 
different mechanisms that can lead to ligand-independent EGFR activation. Interestingly, two 
of them, namely phosphorylation of EGFR by Src and inhibition of PTPs, are thought to be 
regulated by ROS79,86. Therefore, it is interesting that higher H2O2 level as for instance caused 
by HRas G12V transformation enhance phosphorylation of monomeric EGFR, whereas 
phosphorylation levels of ligand-stimulated EGFR are comparable in both cells types. In 
summary, the here presented results show that inhibition of PTPs, as induced here by HRas 
G12V induced H2O2 production, does not mediate EGFR dimerization but facilitates a higher 
phosphorylation of the monomer. This points to different mechanisms for ligand-dependent 
vs. independent EGFR activation in BJ cells.  
Ligand-independent EGFR activation has been already described before80, but in how 
far signaling from the phosphorylated monomer differs to the one of phosphorylated dimers 
is still vaguely investigated. For a deeper understanding of the phosphorylation dynamics of 
EGFR, we performed single cell analysis of unstimulated and EGF stimulated BJ cells 
expressing EGFR-mCitrine and checked for phosphorylation of different tyrosine residues, 
each representing a distinct cellular function (Figure 4.16, Figure 4.17, Figure 4.18). For the 
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autocatalytic site Y845 a clear correlation between expression level and phosphorylation was 
detected in both cell types, indicating spontaneous phosphorylation of this site in the EGFR 
monomer. Interestingly, relative phosphorylation was higher in HRas G12V transformed cells 
when compared to similar EGFR expression levels in wt cells. This indicates that the threshold 
for spontaneous EGFR activation in G12V cells is lower than in wt cells, which might be 
caused by a lower PTP net activity in those cells. If this effect is purely determined by H2O2 
remains to be further investigated by specific inhibitor experiments. In addition, it is also 
possible that HRas itself affects other network motifs that increase Y845 phosphorylation like 
increased Src activation, which in turn would activate EGFR.  
When stimulated with EGF, the difference in Y845 phosphorylation between HRas 
G12V cells and wt cells is even more pronounced, with a higher phosphorylation in G12V 
cells (Figure 4.16). This is contradictory to the previous results, where no difference in EGFR 
phosphorylation between wt and G12V cells was detectable when stimulated with saturating 
EGF concentrations. One reason for that might be that detecting EGFR activation via PY72, 
PTB translocation or PhosTag, as used before, are not able to detect Y845 phosphorylation. 
This could indicate that both autonomous and EGF-induced autocatalytic EGF activation are 
indeed higher in G12V transformed cells but just specific phospho-sites are hyper-
phosphorylated. The site-selective hyperphosphorylation caused by increased H2O2 levels was 
already shown for PDGFR, proposing a similar mechanism for EGFR152. Regulatory 
mechanisms that are unaffected by Ras signaling itself or H2O2 could keep relative 
phosphorylation of other tyrosines residues in check. For instance, PTPs that are not inhibited 
by H2O2 keep dephosphorylating distinct tyrosine of EGFR.  
However, phosphorylation of Y845 is a prerequisite for EGFRs kinase activity and 
higher levels in pY845 should also be represented by other autophosphorylation sites142. 
Therefore, we checked for Y1068 phosphorylation, a signaling tyrosine that serves as docking 
site for Grb2. Interestingly, unstimulated G12V cells showed also a correlation between 
increasing Y1068 phosphorylation and higher receptor density (Figure 4.18). This effect was 
less pronounced in wt cells, although data are noisy and quantification of more cells is needed 
to draw a clear conclusion. Upon EGF stimulation, in particular G12V cells showed a fraction 
of cells with low EGFR expression level but high phospho-to-total ratio. This effect is probably 
caused by antibody binding to endogenous phosphorylated receptor creating artifacts in the 
here presented data. Therefore, this experiment should be repeated with a different antibody 
or in cells that express low levels of endogenous EGFR.  
   96 
Another phosphorylation site that was investigated here is Y1045, a docking site for 
Cbl and therefore important for EGFR ubiquitination and degradation153,154. Interestingly, this 
site is not affected by oxidative stress155 and just effectively phosphorylated in the dimer80, 
which can be confirmed since no autonomous phosphorylation of this site was detected for 
both cell types (Figure 4.17). When stimulated with EGF, both cell types showed a clear 
increase in phosphorylation when compared to unstimulated cells. As for the other tyrosine 
residues, Y1045 phosphorylation was already saturated at low EGFR concentrations and no 
correlation between receptor expression and pY1045 was detectable. In accordance to Y845 
phosphorylation, EGF-induced Y1045 phosphorylation was higher in G12V cells. However, as 
explained before, pY1045 leads to EGFR internalization and subsequent degradation. Thus, 
higher phosphorylation of this site in G12V cells could indicate an enhanced degradation rate, 
which could counteract the increased phosphorylation of Y845 leading to similar 
phosphorylation levels of other tyrosine residues that were investigated before (Figure 4.10, 
Figure 4.11, Figure 4.13). This hypothesis needs to be verified by further experiments, which 
should be emphasized on receptor ubiquitination and internalization rates.  
By overexpressing EGFR, we provoked spontaneous phosphorylation due to high 
receptor density at the PM facilitating tyrosine phosphorylation by increasing the chance of 
random collisions. Under endogenous EGFR expression levels, the autocatalysis in the EGFR 
system can be detected by an EGF dose response, when a linear increase in ligand leads to a 
non-linear rather sigmoidal increase in receptor phosphorylation. This is accomplished by 
ligand-activated dimers that propagate the signal to non-ligand bound monomers and a 
simultaneous inhibition of PTPs by H2O286,94. Under saturating ligand concentrations all 
receptors are fully active and in a dimeric state making higher H2O2 level in G12V cells 
probably redundant when it comes to EGFR phosphorylation. This is in line with the 
previously discussed experiments where no clear difference in EGFR phosphorylation 
between wt and G12V cells was detected. Therefore, we performed an EGF dose response 
experiment to identify the threshold at which EGFR gets activated in wt and G12V cells. 
However, no significant difference in tyrosine phosphorylation between both cell types was 
detected (Figure 4.15). Phosphorylation of Y845 was not detected here although this site 
showed clearly a higher phosphorylation when EGFR-mCitrine was overexpressed in G12V 
cells as compared to wt cells. This raises the question of how EGFR activation is defined. 
Simple antibody-stainings against one phospho-tyrosine do not adequately represent the 
complexity of EGFR activation and trafficking dynamics. Both of these processes combined 
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determine the EGFR activation status and should be therefore considered together. The 
combination of imaging experiments to map EGFR activation in a spatial context and 
biochemical experiments for the detection of the phosphorylation of distinct tyrosine could 
give a more detailed insight into the discrepancies in EGFR activation between wt and G12V 
cells caused by higher H2O2 levels. 
Another way to investigate EGFR signaling activity is the analysis of downstream 
molecules, which get phosphorylated in response to EGF stimulation. Here, we focused on the 
two most prominent signaling cascades, the Ras/MAPK and PI3K/AKT pathway. 
Phosphorylation of ERK, representing activation of the MAPK pathway, was higher in 
unstimulated G12V cells as in wt cells, most likely caused directly by the constitutively active 
form of HRas. Upon EGF stimulation, phosphorylation levels between both cell types were 
comparable, in consistence with the similar pY1068 levels of EGFR obtained before (Figure 
4.10). Interestingly, in unstimulated cells AKT activation, which is spatially restricted to the 
PM, was the same between both cell types but upon EGF stimulation G12V cells showed 
higher phospho-AKT level (Figure 4.19). This effect might be evoked either by HRas G12V 
itself or by the increased H2O2 levels, which have been shown to inhibit PTEN and thereby 
increase AKT activation54,55.  
Since the PI3K activity is also necessary for the formation of NOX complexes and 
H2O2 production3,156, activation of its effector AKT is of main interest for this study. 
Therefore, we performed an EGF dose response experiment, detecting AKT phosphorylation 
as readout. The AKT phosphorylation profile differed significantly from the EGFR 
phosphorylation profile (Figure 4.15, Figure 4.20). In wt cells AKT phosphorylation saturated 
at a comparably low EGF concentration and even decreased with higher EGF concentrations. 
This phosphorylation profile indicates negative regulation of AKT signaling at high EGF 
concentrations157. It was shown before that EGF concentrations above 20 ng/ml induce the 
internalization via clathrin-independent pathways leading to EGFR degradation instead of 
recycling118. However, full AKT activation requires clathrin scaffolds suggesting that upon 
stimulation with high EGF concentrations, only a fraction of active EGFR leads to AKT 
phosphorylation158. Interestingly, AKT activation in G12V cells represents more a sigmoidal 
activation curve similar to the EGFR activation profile. Further experiments would be 
important to elucidate the mechanism behind these cell type specific variations. However, one 
can speculate that the more switch-like response of AKT phosphorylation in G12V cells could 
be generated for instance by a double-negative feedback as shown for EGFR86,159. The higher 
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production of H2O2 upon EGF stimulation in G12V cells would lead to an enhanced 
inhibition of PTEN in comparison to wt cells. Thus, PIP3 accumulates at the PM and NOX 
can be more efficiently activated leading to even higher levels of H2O2 resembling positive 
autoregulation160. Additionally, former results represented here show that G12V cells have a 
tendency to activate EGFR monomers, which have been shown to activate AKT but not 
ERK80. This would imply that in untransformed cells a switch from AKT to ERK activation 
occurs with increasing EGF concentrations caused by a change in the EGFR internalization 
mechanism (Figure 4.20). Consistent with this hypothesis, phosphorylation of AKT decreases 
at the same EGF concentration at which Y1045 phosphorylation of EGFR is highest indicating 
receptor ubiquitination (Figure 4.15 B, Figure 4.20). Although the relative pY1045 
phosphorylation profile of G12V cells was similar to that observed in wt cells, the western blot 
analysis does not reveal how much EGFR is in a dimeric vs. monomeric state. A fraction of 
H2O2-activated monomers, negative for pY1045, in G12V cells would be able to activate AKT. 
In addition, this population of EGFR might be also promoting the here presented higher H2O2 
production upon EGF stimulation (Figure 4.8). To proof this theory it would be important to 
investigate EGFR activity with regard to the receptors dimerization state and untangle 
signaling from EGFR monomers from that of EGFR dimers.   
In summary, the simple explanation that an oncogene-induced raise in H2O2 decreases 
the net PTP activity resulting in a more trigger-friendly EGFR system was not fully confirmed 
by this study. These experiments illustrate that a simple detection of EGFR phosphorylation is 
not sufficient to map the distinct signaling modes of EGFR in relation to the spatial 
organization of the receptor and how these can be affected by HRas G12V dependent H2O2 
production. However, the increased phosphorylation of the autocatalytic site Y845 in G12V 
cells indicates an increased autocatalytic activity of EGFR. Further investigations with regard 
to specific tyrosine residues are needed to reveal if the overall catalytic activity of EGFR is 
enhanced in G12V cells or if homeostatic mechanisms reduce an increased EGFR signal 
activity.  
5.3 Homeostasis in HRas transformed cells 
Malignant transformation of cells by the constitutive activation of an oncogene, as 
studied here, are frequently used model systems to investigate cancer signaling networks in 
cells. By introducing one oncogene, several networks motifs are getting perturbed and need to 
be integrated to ensure the survival of cancer cells161. This can lead to tumor specific drug 
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resistance, which could be prevented by understanding the effects on the signaling network 
level evoked by the oncogenic lesion119,140.  
Here, we found several indications that adaptive mechanisms in G12V cells are 
established to counteract the higher endogenous H2O2 level, thereby ensuring survival and 
proliferation rather than sensecence109,162. When the Hyper3 constructs were tested in BJ cells 
for their oxidation and reduction potential, G12V transformed cells showed a lower fold 
increase in the HyPer3 ratio than wt cells when treated with exogenous H2O2 (Figure 4.4, 
Figure 4.5). In line with that, all constructs showed a faster reduction in G12V cells when 
treated with DTT in particular the cytoplasmic construct cHyPer3 (Figure 4.4, Figure 4.5). 
This is counterintuitive to the higher basal H2O2 levels and the higher fold increase of H2O2 
upon EGF stimulation in G12V cells (Figure 4.1, Figure 4.8). One explanation for this could 
be that the higher basal H2O2 levels in G12V cells already partially oxidize HyPer3 and 
treatment with exogenous H2O2 does not lead to the same fold increase as compared to wt 
cells due to sensor saturation. The fast reduction could be provoked by a more potent 
antioxidant system in BJ G12V cells that is necessary to cope with higher endogenous H2O2 
concentrations. In line with this, it has been shown by other studies that adaption to high ROS 
levels is common in cancer cells163,164.  
We could also show that inhibition of NOX proteins via DPI leads to a significant 
decrease in cellular survival/proliferation in G12V cells, whereas a reduced growth rate in wt 
cells was only detected for high DPI concentrations (Figure 4.2). In addition to that, EGFR 
phosphorylation upon EGF stimulation was strongly reduced in G12V cells when treated with 
DPI, whereas no effect was detected for wt cells (Figure 4.12). In the opposite case, increasing 
ROS levels by treatment with exogenous H2O2, led to a striking autonomous activation of 
EGFR in G12V cells. In contrast, ligand-independent EGFR activation in wt cells could be 
only detected upon treatment with high H2O2 concentrations (Figure 4.14). This shows that 
G12V cells not only have to adapt to higher H2O2 levels to ensure survival but also are 
dependent on it for proper EGFR signaling and cellular growth. 
In summary this points to the fact that, although not directly elevating EGFR 
phosphorylation, H2O2 production is necessary for full receptor activation upon EGF 
stimulation in G12V, where only a slight elevation of the intracellular H2O2 concentration led 
to autonomous receptor activation. This indicates that adaptive mechanisms keep EGFR 
phosphorylation under growth factor stimulation in check, whereas small perturbations such 
as higher ROS levels can lead to abnormal EGFR signaling. Several feedback loops might 
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downregulate EGFR phosphorylation in a more oxidative environment preventing 
hyperphosphorylation in G12V cells. For instance, it was shown that activation of ERK leads 
to the phosphorylation of Thr669 in EGFR correlating with decreased tyrosine 
phosphorylation and thus EGFR activation165. Constitutive activation of HRas enhanced ERK 
activation upon ligand stimulation resulting in Thr669 phosphorylation in G12V cells 
lowering EGFR tyrosine phosphorylation. Another negative feedback mechanism, which is 
regulated via the Ras/MAPK pathway, is the activation of the dual-specificity phosphatase 
CDC25c. EGFR dephosphorylation is correlated with CDC25c activation, a feedback loop 
causing drug resistance of colon cancer patients treated with a BRAF inhibitor140. Although 
there are also reports of H2O2 induced inhibition of CDC25c166, its cytoplasmic localization 
could lead to a rapid exchange between inactivated and activated molecules still mediating 
EGFR dephosphorylation. Therefore, PTP localization could be a determinant for its 
oxidation susceptibility favoring PTP oxidation of spatially restricted PTPs like RPTPs or ER-
anchored PTPs like PTP1B and TCPTP over cytoplasmic PTPs like CDC25c. 
In general, we assume that PTPs catalyze dephosphorylation of their target proteins 
and thus mediate downregulation of RTK signaling. However, there are also oncogenic PTPs 
known that for example enhance EGFR activity like PTPD1167 or mediate EGFR signaling and 
tumor growth as shown for SHP2168-171. Oxidation and inactivation of those PTPs would lead 
to decreased EGFR activity resulting in a negative feedback and not a double-negative 
feedback loop. Hence, a detailed investigation of the existing EGFR-PTP network topology in 
resting and EGF stimulated cells is necessary to elucidate how EGFR response properties are 
shaped by recursive interactions with PTPs and how those can be affected by H2O2. 
5.4 PTP activity determining RTK phosphorylation dynamics 
As stated out before, PTP oxidation and its effect on RTK activity is, despite great 
progress that was made over the last years, still one of the enigmas of RTK signaling. RTK 
phosphorylation dynamics are thought to be dictated by the receptors autocatalytic activity 
and its recursive interaction with PTPs172. Coupling between RTK activation and PTP 
inhibition is mediated by H2O2 and oxidation-mediated inactivation has been confirmed for 
several PTPs so far42,57. However, systematic approaches detecting the spatial-temporal 
dynamics of PTP oxidation upon GF stimulation and with respect to RTK activation are still 
missing.  
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5.4.1 HRas-induced H2O2 increases basal PTP oxidation 
The challenge in studying ROS signaling is on the one hand the precise detection of 
ROS itself and on the other hand mapping the oxidation of target proteins correctly. Protein 
oxidation belongs like protein phosphorylation to the group of posttranslational 
modifications regulating protein activity, protein-protein interactions and protein stability. 
However, redox modifications such as the here-investigated S-sulfenylation (-SOH) are highly 
labile and dynamic making them hard to detect173. In this study, we used labeling of sulfenic 
acid with either native dimedone20 or DYn-2, a cell-permeable alkyne-functionalized 
dimedone analogue40. Dimedone-derivatization of oxidized proteins in live cells, as used here, 
has the advantage of maintaining the native cellular redox environment whilst enabling the 
labeling of fixed cells for further analysis.  
For the detection of dimedone-derivatized proteins an antibody was used that 
recognizes this epitope specifically62. We could show that the catalytic domain of PTP1B gets 
oxidized upon treatment with H2O2 in vitro (Figure 4.21). Further analysis of endogenous 
PTP1B in cells showed susceptibility of this PTP towards H2O2-mediated oxidation. However, 
the signal-to-noise ratio was quite low although exogenous treatment with H2O2 should 
exceed H2O2 levels that are produced upon GF stimulation leading to the full oxidation of 
PTP1B (Figure 4.22). Thus, we used ectopic expression of PTP1B-mCitrine and SHP2-
mCitrine to provide a greater pool of available substrate for oxidation. In contrast to wt cells, 
HRas G12V transformed cells showed a significant increase in oxidation for both PTPs upon 
treatment with H2O2 (Figure 4.23). This indicates that higher endogenous H2O2 level caused 
by constitutively active HRas add up with exogenous H2O2, oxidizing and inhibiting PTPs 
more efficiently. This is in line with the higher ligand-independent activation of EGFR in 
G12V cells provoked by treatment with exogenous H2O2 (Figure 4.14). Basal oxidation of 
PTP1B-mCitrine and SHP2-mCitrine were also slightly increased in G12V cells when 
compared to wt cells, possibly causing the detected elevated EGFR phosphorylation in 
unstimulated G12V cells (Figure 4.11, Figure 4.13).  
Without ligand stimulation, the ER-anchored PTP1B is important to suppress 
spontaneous RTK phosphorylation through the vesicular recycling of activated monomers 
from the PM to the perinuclear area, which is characterized by high PTP1B activity80,81,90. A 
higher basal oxidation of PTP1B might explain therefore the higher basal phosphorylation of 
EGFR in G12V transformed cells. However, it is still unclear why a higher inhibition of PTPs 
by HRas G12V-mediated H2O2 does not affect EGF-mediated receptor phosphorylation. For 
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further elucidating this discrepancy, we established an imaging approach for the spatial-
temporal detection of protein oxidation by using the probe DYn-2 (Figure 4.27, Figure 4.28).  
5.4.2 RTK activity patterns linked to PTP oxidation 
By monitoring the spatially distinct phosphorylation pattern of EGFR upon EGF 
stimulation it is striking that upon ligand stimulation receptor activation is highest at the PM 
and declines upon internalization (Figure 4.11). Interestingly, when cells were treated with 
H2O2 to evoke ligand-independent EGFR activation, phosphorylation extended even to 
receptors on endomembranes since H2O2 levels and thus PTP inhibition are not spatially 
confined86. In contrast, EGF stimulation creates two opposite gradients; high H2O2 levels at 
the PM decreasing towards the cell interior2 and high PTP activity in the perinuclear area 
declining towards the cell periphery90. This difference in spatial confinement of PTP 
inhibition could explain the discrepancy in EGFR phosphorylation between wt and G12V 
cells when treated with EGF vs. H2O2 (Figure 4.10, Figure 4.14, Figure 4.15). For instance, 
recycling/internalization in G12V cells could be faster upon EGF stimulation resulting in a 
more efficient dephosphorylation of receptors by ER-anchored PTPs, which are mostly 
unaffected by H2O2 accumulated at the PM. Although not detected at endogenous EGFR level, 
we could show a higher phosphorylation of Y1045 upon EGF stimulation in G12V cells when 
the receptor was overexpressed supporting this hypothesis (Figure 4.17). Another explanation 
could be a pool of PTPs that are freely diffusible and therefore less affected by spatially 
confined H2O2 production as stated before for CDC25c. A negative feedback created when 
those PTPs are either activated by EGFR, Ras or their downstream effectors could counteract 
an increased H2O2-mediated inhibition of other EGFR regulating PTPs.  
To further investigate spatially distinct PTP inhibition, we developed an approach to 
monitor protein oxidation in cells. We focused on SHP2, a phosphatase that has been shown 
to be both a negative and a positive regulator of EGFR signaling. Once activated, SHP2 binds 
via its SH2 domain to phosphorylated EGFR directly or via tyrosine-phosphorylated adapter 
proteins stimulating the activity of Ras/ERK/MAPK signaling, marking SHP2 as a ‘proto-
oncogene’174,175. In addition, SHP2 also dephosphorylates the autophosphorylation site Y992 
of EGFR, which acts as a binding site for RasGAP, a GTPase-activating protein catalyzing Ras 
inactivation137. On the other hand, phosphorylation of Y992 has been shown to mediate 
PLCγ1 activation resulting in Rac1 activation, important for membrane ruffling and H2O2 
production92,100,176.  
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ROS-dependent inhibition of SHP2 has been shown before for PDGF stimulation45, 
EGF stimulation40 and in this study upon treatment with H2O2 (Figure 4.23, Figure 4.28). 
Imaging SHP2 oxidation with the here established FRET-FLIM approach shows that it is 
higher in unstimulated G12V cells correlating with higher basal H2O2 level and autonomous 
EGFR activation (Figure 4.29). Upon treatment with H2O2 both cell types showed the 
formation of SHP2-SOH, whereas higher H2O2 concentrations led to the formation of 
irreversible oxoforms like sulfinic (-SO2H) or sulfonic acid (-SO3H) indicated by a decreased 
binding affinity of DYn-2 (Figure 4.29). EGF stimulation led to a significant oxidation of 
SHP2 in both cell types reflecting inhibition of the phosphatase since the catalytic deficient 
mutant (C/S substitution) was neither affected by H2O2 treatment nor by EGF stimulation 
(Figure 4.30). The unresponsiveness of the C/S mutant also proves that just the catalytic 
cysteine gets oxidized due to its low pKa value and that oxidation of PTPs thus inhibits their 
catalytic activity. In general, it is remarkable that G12V cells show a much higher variability 
than wt cells both upon H2O2 treatment and EGF stimulation. In general, it is beneficial for a 
cell population to maintain heterogeneity in a fluctuating, unpredictable environment, as it is 
the case for cancer. Cellular variation is thereby ensuring robustness and is in the case of 
cancer associated with resistance to anticancer therapies83,177. An enhanced variation is 
normally a characteristic of positive regulation and with regard to the RTK-PTP network an 
indication for the H2O2 mediated double negative feedback160.  
The here presented technique provides a first step towards the spatial-temporal 
monitoring of protein oxidation in single cells. This approach can be combined with 
immunostainings to map for instance EGFR phosphorylation simultaneously and can be 
extended to any protein of interest. With regard to our question it would be important to 
investigate oxidation of other PTPs important for generating the here observed EGFR 
phosphorylation profile in wt and G12V cells.  
 
In summary, this and other studies suggest to divide PTPs in three different classes 
with regard to EGFR regulation:  
 -­‐ ER-anchored PTPs like PTP1B and TCPTP with high catalytic activity, 
dephosphorylating recycling EGFR molecules and terminating EGFR activity upon 
EGF stimulation 
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-­‐ Cytosolic, recruitable PTPs including SHP1 and SHP2 more important to 
activate/deactivate downstream effector proteins upon EGF stimulation -­‐ Receptor PTPs, which are more likely to inhibit spontaneous EGFR activation at the 
PM and determining EGFRs responsiveness to EGF 
 
Depending on the PTPs susceptibility to oxidation and its dephosphorylation target, 
distinct RTK-PTP network topologies can be distinguished creating different RTK activity 
patterns (Figure 5.1)94,96. It is important to separate, which PTPs are more important signal 
duration upon EGF stimulation and which regulate spontaneous activation and 
responsiveness. By untangling this, it would be possible to explain why autonomous activation 
is elevated in HRas G12V transformed cells whereas EGF induced phosphorylation is similar 
between both cell types.  
 
 
Figure 5.1: Examples of possible RTK-PTP network motifs 
This scheme represents different possibilities for the interaction of PTPs with RTKs. When the PTP is inhibited 
upon RTK-induced H2O2 production either a double-negative feedback (1) or a negative feedback (2) can be 
generated. A negative feedback is created when the RTK activates its own inhibitor as for instance known for 
SHP1/SHP2 (3). When the PTP amplifies RTK activation e.g. by Src activation or by dephosphorylating tyrosine 
residues that negatively regulate RTK activation, a positive feedback is established (4). When the PTP just 
dephosphorylates the receptor the interaction is stated as simple negative regulation (5).  
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6 Outlook 
With this work, we created the first step towards a more detailed understanding of the 
biology of ROS signaling. By generating an approach to detect protein oxidation in space and 
time it is possible to uncover several enigmas of ROS biology such as target selectivity or 
compartmentalization.  
We focused our work on the RTK-PTP network and how this could be affected by the 
pathological rise of H2O2 caused by constitutively active HRas.  In sum, we observed that EGF 
provoked EGFR phosphorylation is nearly unaffected in HRas G12V transformed cells 
whereas basal receptor activation is elevated. For a deeper understanding of the mechanism 
behind this finding, a detailed analysis of PTP oxidation is needed. By extending the here 
presented approach for imaging protein oxidation to other PTPs, different network motifs 
shaping the here detected EGFR phosphorylation profile could be identified. Interesting 
candidates are members of the RPTP family since their shared localization with EGFR might 
indicate that they are responsible for regulating autonomous receptor activation and ligand 
responsiveness. Structurally they also share the catalytic cysteine with a low pKa and oxidation 
and subsequent dimerization upon H2O2 treatment has been already shown for PTPRA178. 
This would create a double-negative feedback between EGFR activation and PTP oxidation at 
the PM, important for robust, threshold-controlled receptor activation. If this network 
topology exists under physiological H2O2 concentrations, as generated upon EGF stimulation, 
and which RPTPs regulate EGFR activation needs to be further verified. 
It would be also important to identify PTPs that are not affected by EGF-induced H2O2 
or even more active upon EGFR activation due to a positive feedback. This group of PTPs 
could sustain homeostasis of EGFR signaling keeping ligand-provoked receptor 
phosphorylation similar between wt and G12V cells. One possible candidate also belongs to 
the receptor-type PTPs. Former studies have shown that PTPRE dephosphorylates and thus 
actives Src179,180. Src activation is necessary for full EGFR activation and a PTP that activates 
Src would positively regulate EGFR activation.  Interestingly, PTPRE is structurally related to 
PTPRA, which has been shown to be susceptible to oxidation-induced inhibition178. 
Therefore, inhibition of PTPRE through H2O2 would impair full EGFR activation in a negative 
feedback. In general, it would be necessary to globally identify, which PTPs are interacting 
with EGFR, the existing network topology and if this interaction is coupled by H2O2. This 
   106 
would extend the knowledge of EGFR signaling to a new level by connecting protein 
phosphorylation with protein oxidation.  
Another interesting aspect that was not investigated here is the direct oxidation of 
EGFR, which has been shown to increase its kinase activity40. So far it was just shown for A431 
cells, a cell type with an extremely high expression rate of EGFR181. If EGFR oxidation is 
indeed important for physiological cell signaling needs to be verified in other cellular models. 
However, oxidation of EGFR and thereby increasing its own catalytic activity by triggering the 
production of H2O2 would be a new mechanism proving EGFR autocatalysis.  
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